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SOMMAIRE 
L'utilisation de Technologies d'Analyse de Precede (PAT) est de nos jours repandue a travers l'industrie 
pharmaceutique, principalement par ce qu'elles permettent d'approfondir les connaissances des precedes, de 
mieux en suivre les differentes etapes, de baisser les couts associes aux traditionnelles methodes chimiques 
de mesure et d'augmenter l'efficacite globale des processus. La plupart des methodes PAT sont basees sur 
des modeles predictifs multivaries (MVPM). La calibration de ces MVPM est une etape cruciale au succes 
du developpement des methodes PAT-MVPM. 
De ce qui a pu etre observe des pratiques courantes en calibration MVPM, les tendances actuelles sont 
alignees sur le mantra «le plus le mieux ». Ceci signifie que les meilleures pratiques suggerent qu'utiliser 
plus de points de calibration, avec plus d'echantillons, fabriques le plus possible comme ceux commerciaux, 
avec des methodes de mesure reference les plus precises possible, menera a des PAT-MVPM plus precis et 
plus performantes. Evidemment, cela menera egalement a des methodes plus dispendieuses and plus longues 
a developper, limitant ainsi leurs applications potentielles en meme temps que le ratio gain-depense de ces 
methodes. 
Le but du present travail etait d'investiguer le protocole de developpement de ces methodes PAT-MVPM 
pour identifier les facteurs les plus susceptibles d'influencer les performances des methodes developpees, et 
ultimement de proposer un protocole optimise. Un cas de base de PAT-MVPM a ete utilise pour faire 
l'etude: l'utilisation de spectres Raman de comprimes pharmaceutiques intacts pour predire leur contenu en 
4 mineraux et 1 vitamine. A partir de ce cas general, 2 mineraux ont ete choisis pour faire partie de la 
recherche : un present en haute concentration dans le produit et l'autre, en basse concentration. 
Huit (8) facteurs ont ete identifies et testes separement sur les deux banques de donnees creees. Les tests ont 
ete geres par un design d'experience qui a permis d'optimiser le nombre total de modele predictif devant etre 
faits, tout en retenant suffisamment de donnees pour minirniser les confusions entre les interactions 
factorielles de second ordre. 
L'analyse des resultats obtenus a partir de plus de 85 modeles multivaries a permis d'identifier les facteurs 
ayant une influence sur les 2 types de calibration (haute et basse concentration de mineraux). Aucun des 
parametres suivants n'ont influence la precision des modeles lors des tests avec l'ingredient hautement 
concentre: le type d'equipement et le volume de batch utilises pour la fabrication des echantillons de 
calibration, le nombre de points et de replicas utilises (jusqu'a un certain point), le type d'algorithme de 
calibration et la methode de mesure de reference. Pour ringredient faiblement concentre, les facteurs 
significatifs etaient le type d'equipement utilise et le nombre de points de calibration. Dans les deux cas, la 
distribution des points sur la courbe de calibration s'est revele etre un facteur significatif par rapport a la 
performance des methodes. 
L'identification de ces facteurs a permis l'elaboration d'un protocole optimise pour developper les PAT-
MVPM. Utiliser cette approche alternative devrait permettre de reduire Pinvestissement necessaire en heure-
homme et heure-laboratoire d'environ 30 %. Une reduction des couts de developpement de 31 % est 
egalement attendue. Ces resultats peuvent etre atteints avec une perte de precision variant de 0 a 2 % (valeurs 
absolues), dependant du niveau de concentration du materiel suivi. 
Cette etude rempli un manque dans la litterature publiee. En effet, a la connaissance de l'auteur, aucune etude 
complete et approfondie du developpement de ces methodes PAT-MVPM n'avait ete fait. Plusieurs pistes de 
recherches futures sont proposees pour la poursuite du projet. 
MOTS CLES: Technologies d'analyse de precede (PAT), Spectroscopic Raman, Pharmaceutique, 
Analyse multivariee, Optimisation, Design d'experience, Comprimes intacts 
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ABSTRACT 
The use of Process Analytical Technology (PAT) is nowadays well spread throughout the pharmaceutical 
industry, mostly because they allow gaining useful process insight, better monitoring throughout the 
manufacturing steps, lowering costs associated with the use of wet-chemistry based testing method, and 
increasing overall efficiency. Most of the PAT methods are based on multivariate predictive models 
(MVPM). The calibration of such MVPM is a step crucial to the success of the MVPM-based PAT method 
development. 
From what could be gathered of today's practices in MVPM calibration, the current trends are aligned on the 
mantra "the more the better". This means that best-practices suggest that using more calibration points, with 
more samples, manufactured as closely as possible to the commercial samples, with more precise measuring 
reference methods, will lead to a more precise, better performing MVPM-based PAT methods. Obviously, it 
also leads to a costlier and longer to develop method, thus limiting the potential applications as well as 
lowering the overall gain to expense ratio of these methods. 
The aim of this work was to investigate the development protocol of MVPM-based PAT methods in order to 
identify the factors that were most susceptible to influence the performances of the developed method, with 
the ultimate goal to propose an optimized protocol. A base case of MVPM-based PAT method was used to 
perform the assessment: the use of Raman spectra collected from intact pharmaceutical tablets to predict their 
content in 4 minerals and 1 vitamin. From this development case study, two minerals were chosen to be part 
of the investigation: one that was in high concentration in the product and one that was in low concentration. 
Eight (8) factors were identified and tested separately on the two data sets created. The tests were guided by a 
design of experiment that allowed optimizing the total number of predictive models that needed to be made, 
all the while retaining sufficient data to allow minimal confusions within second-order factorial interactions. 
Analysis of results gathered from more than 85 multivariate predictive models allowed identifying factors 
that had an influence on both type of calibration (high and low raw material concentration). The type of 
equipment and batch size used for calibration samples manufacturing, as well as the number of points and 
replicates use (to a certain extent) or the calibration algorithm and reference method did not influence the 
MVPM accuracy when dealing with highly concentrated raw material. For a low-concentration raw material, 
the significant factors were the type of equipment and number of calibration points used. In both cases, the 
distribution of the calibration points along the chosen concentration span showed a significant influence on 
the method performances. 
Having identified the factors influencing the MVPM-based PAT method, an optimized protocol for future 
development could be proposed. Using this alternate approach should reduce the required invested man- and 
lab-time by approximately 30 %. A 31 % reduction in development-related costs is also expected. These 
results can be achieved with a manageable accuracy decrease varying between 0 and less than 2 % (absolute 
values), depending on the type of raw material concentration monitored. 
This study fills a gap in the published literature. No extensive and comprehensive studies had been made, to 
the author's knowledge, regarding the overall development process of such MVPM-based methods. Several 
hints for future research and developments are also proposed to follow-up with this project. 
KEY WORDS: Process Analytical Technologies (PAT), Raman Spectroscopy, Pharmaceutical, 
Multivariate analysis, Optimization, Design of experiment, Intact tablets 
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Henri Poincare (1854 - 1912) 
"AproBtem xueti stated is aproBtem fiaCf-sotved" 
Charles F. Kettering (1676-1958), unsourced 
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Context 
Pharmaceutical companies are nowadays facing new challenges which bring them to seek 
more and more ways to improve their activities. 
With each patent coming to its expiry date, the owning company has to deal with financial 
pressure coming from generic manufacturers. Because the latter do not have to cover the cost 
of research and development of the product, they can afford to sell it at a price lower than the 
leading company, hence creating a pressure towards lowering prices [Danzon, 2008]. 
Moreover, pharmaceutical companies also face an increasing demand for quality monitoring. 
Usual end-of batch quality monitoring is not only expensive, it also increases the risk of total 
batch failure to meet quality expectations; proceeding to quality tests when the batch is ready 
to be sold means that if quality standards are not met the whole batch is lost. And this does 
not come at a cheap cost. 
When adding to these factors increasing costs of raw materials and utilities, the equation 
easily solves toward the need for pharmaceutical industry to embrace these challenges and 
find ways to overcome it all. 
Far from being clueless when facing this situation, the pharmaceutical industry, supported by 
the FDA, has found answers to these challenges. Actors in this domain needed to: 
. increase quality and quality-control of their product; and 
• decrease overall manufacturing cost of products. 
Solutions found and adopted can be summarized as 1) changing the quality approach and 2) 
implementing leaner processes. 
One of the ways to achieve this is by implementing Process Analytical Technologies (PAT) in 
the manufacturing processes. Defining PAT is not straightforward, as their use is widespread 
and wide-ranged. Bakeev defines a PAT as an "analysis of the process [...] for the 
improvement of process development and control". PAT are distinguished from laboratory 
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analysis in the sense that they are faster and require no manual sample handling, hence 
allowing "the opportunity for live feedback" [Bakeev, 2005]. 
In an effort to move quality from end-point testing to built-in/by design quality concepts, the 
United States' Food and Drug Administration (FDA), following open discussions with the 
pharmaceutical industry, published two Process Analytical Technology (PAT) guidance 
documents, in 2002 and 2004 [US FDA, 2002; US FDA, 2004]. This new regulatory 
acceptance of PATs allows the pharmaceutical industry to join petro- and chemical industries 
in the race to better analyze, understand, monitor and control their process in order to increase 
production and quality while lowering unit cost and process failure occurrence [Sasic, 2008]. 
On top of all efforts made toward leaner and more efficient processes, a new concept was 
introduced in the pharmaceutical industry to support the current effort. The concept, referred 
to as Quality by Design (QbD), invites to use PATs - and other techniques - to build the 
quality into the products, rather than to rely on a fixed process that gives product which 
quality is tested only at the end of its manufacturing. More formally, QbD is defined by the 
International Conference on Harmonisation (ICH), as "a systematic approach to development 
that begins with predefined objectives and emphasizes product and process understanding and 
process control, based on sound science and quality risk management" [US ICH, 2008]. 
In other words, it suggests that previous knowledge and thorough study, right in the beginning 
of the product formulation, be used to better define a design space that will ensure final 
product's quality. Using appropriate controls to maintain the process in the design space then 
allows reducing end-point testing, thus resulting in a shift from Quality by Testing (QbT) to 
Quality by Design. 
PAT tools in the pharmaceutical industry and at Wyeth Montreal 
Wyeth Pharmaceuticals has long been collaborating with University of Sherbrooke, first 
through the hiring of coop students in engineering, then in the context of NSERC projects and, 
since June 2008, through a Chair1, to elaborate PAT tools that fit Wyeth's need while 
"Wyeth Process Analytical Technology Chair in Pharmaceutical Engineering"; "Chaire Wyeth sur les 
technologies d'analyse des procedes en genie pharmaceutique". 
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State of the art in developing MVPM-based PAT 
The development of a Multivariate predictive model (MVPM) that will become the core of a 
PAT includes several activities that can be separated in 4 larger steps. Several questions arise 
when dealing with each of these steps and the decision taken regarding each - and many 
other- question can have consequences on the final method performances as well as the 
efforts required to achieve its completion. An overview of the development steps and related 
question examples are detailed in Figure 0.1. 
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Figure 0.1: Overview of development steps for MVPM-based methods 
One of the principal concerns expressed by authors in published studies concerning 
development of MVPM-based applications regards sample preparation for model calibration. 
Samples must be prepared in such a way that they are as close as possible to future "real" 
samples the model is developed for. As such, small-scale and production-like pilot equipment 
are often used, as outlined in Table 0.1. 
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Table 0.1: Review of calibration methods presented in published papers 
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single station automatic press 
infrared presser for pellets 
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pellets 
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12.5 
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20 
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0 to 400 
70 to 130 
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70 to 130 
0 to 162 
9 
20 
4 
N/Av 
3 
5 
5 
3 
9 
5 
28 
N/Av 
28 in total 
28 in total 
36 
10 
23 in total 
500 
30 
Wikstrom, 2006 
Hwang, 2005 
Mazurek, 2006 
Szostak, 2002 
Meza, 2006 
Mattes, 2007 
Wang, 2005 
Colon, 2005 
Cogdill, 2005 
Cournoyer, 
2008 
While this allows obtaining representative calibration samples that provide good coverage of 
the calibration span, it is a very time-consuming and costly activity, sometimes requiring 
months of preparation [Wang, 2005; Blanco, 2001; Huang, 2002; Kramer, 1998]. Indeed, even 
though these equipments are smaller than the original process ones, amounts of raw materials 
required to manufacture in it each calibration level samples remain considerable. Moreover, 
whenever the model is to be applied on either a new product formulation or another product 
altogether, new calibration samples must be prepared. 
Moreover, an interesting parallel can be drawn between the development of a MVPM-based 
PAT and that of a new product. As mentioned earlier, the new trend for the latter is to use 
PAT and other techniques to better understand the process and use this knowledge to perform 
QbD rather than QbT. And yet the development of MVPM-based PAT, as outlined previously, 
relies mostly on past experience and trials and errors. The PAT is developed according to a 
given plan and the quality of the final product (the PAT method) is tested at the end, by 
external validation (see Chapter 1 for more details). If the product quality meets requirements 
then the method is delivered to the client. If not, adjustments are made when possible or a new 
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method is developed. In light of previously presented information, this procedure agrees with 
QbT philosophy more than the QbD one. 
Hence, studying the development process of a MVPM-based PAT method serves two goals: 
bringing the development process from QbT to QbD and potentially reduce the work load 
associated with it, hence multiplying all potential gains associated with the implementation of 
a PAT. 
Problem and objectives 
This project takes place within the activities of the Wyeth/UdeS Industrial Chair and it has 
three main objectives: (1) improve fundamental knowledge in the area of a promising PAT 
(at-line Raman Spectroscopy), (2) convert this knowledge to an industrially useful PAT tool 
and (3) use this knowledge to improve the development protocol of such methods. From the 
industrial standpoint, Wyeth has recently identified a new area of its activities that could 
benefit from the implantation of a PAT: final product quality assessment for release to 
consumers. From the academic standpoint, it was found that there is a gap in literature 
regarding the role of different parameters or characteristics on performance of multivariate 
predictive models based on in-line spectroscopic methods (i.e. Raman spectroscopy) to 
quantify pharmaceutical formulations (i.e. tablets and other forms of particulate mixtures). 
The target products to monitor are in the vitamins and minerals products and Raman 
spectroscopy has been chosen as the measuring method to be evaluated as an alternative to 
current test methods. The development of this project creates an opportunity to study 
multivariate model calibration processes in depth. As will be described in the next Section, 
very few studies have been conducted to establish guidance and/or "rule of thumbs" regarding 
model calibration, leaving this research area wide open for optimization. 
Overall, the problem that is proposed could be defined by the following question: 
"Is it possible I) to determine the influence that calibration parameters have on 
multivariate predictive model performance, II) based on a case study using Raman 
spectroscopy to measure component concentration in a pharmaceutical tablet and 
III) with conclusions that can be generalized to be non case-specific? " 
EiZ 
1. determine calibration parameters to be tested; 
2. determine calibration parameters' influence on model performances; 
3. propose an optimized development protocol. 
Original contribution in the state of the art 
A review of papers did not provide any indication that studies were made to extensively 
compare predictive ability of multivariate models that were elaborated using many different 
calibration approaches, neither with Raman spectroscopy nor with other spectroscopic 
techniques. 
The only paper related to the subject that was found at the moment of the research is by 
Blanco et al [Blanco, 2001], who studied the effects that two sample preparation procedures 
had on the performance of NIRS in quantitative pharmaceutical analyses. The studied 
procedures were "synthetic" and "doped" sample preparation. Synthetic preparation refers to 
raw material powder mixing in laboratory and doped preparation consists of grinding 
commercial tablets in powder and adding to the mix either API (to heighten the concentration) 
or excipients (to lower it). The authors of this study concludes that both preparation methods 
are equivalent in ground commercial sample prediction, but no conclusions are available 
regarding prediction ability for intact sample prediction. The results of this study, however 
interesting, do not allow assessing the problem at hand. 
Few other authors were found to have published on subjects related to the problem outlined. 
Huang et al [Huang, 2002] compared robustness of NIRS-based predictive models elaborated 
using different multivariate techniques. They studied Least Square egression, Ridge 
Regression and PLSR (-2, 3 and 4) in the context of varying data set size. The authors worked 
on fat and protein content prediction in milk samples to determine which method allowed best 
model robustness with lowest calibration data size. They demonstrated "that relative 
performance of calibration methods depends on calibration data size for a given data set." This 
study, while addressing the topic of calibration data size, did not cover calibration data 
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distribution or sample preparation method, hence pointing out the lack of documentation, and 
perhaps the need for it, regarding optimisation of calibration approaches. 
Kramer states three rules of thumb to choose the number of samples that should be included in 
a calibration set. He proposes the "rule of 3", the "rule of 5" and the "rule of 10". These rules 
state that a calibration set should consist of a bare minimum of 3 times the number of samples 
as there are independent sources of significant variation in the data (components); that for 
systems with small number of components, the number of samples should be 5 times the 
number of components; and that for complex system, it should be 10 times that number in 
order to fully represent all possible combinations of component values for the multiple-
component systems [Kramer, 1998]. Although useful, these rule of thumbs do not allow 
concluding on the general "best" approach to model calibration; they do not take into account 
modeling technique used (PLS, PCR, etc) nor the distribution of the calibration data on the 
correct span to cover. 
Hence, it is noted that very few studies have been conducted to establish guidances and/or 
"rule of thumbs" regarding model calibration. Despite the fact that a lot of work and resources 
are required to achieve the development of such methods, no optimization studies were 
published, at the time of research and to the author's knowledge. 
As of this moment, this research area is wide open for optimisation of the calibration 
approaches and for better understanding of the influence the different calibration parameters 
have on the final model's performance. The conclusions of this study should help fill the need 
in that area. 
Moreover, to the author's knowledge, no mention of considering the development of MVPM-
based PAT methods in a QbD philosophy as been made in the literature. 
Plan of document 
This document contains all details pertaining to this work. Starting with a complement of 
theory on selected subjects, the reader will be provided with a detailed overview of the 
methodology adopted. All results obtained are then exposed, along with adequate 
interpretation and conclusions. The annexes contain all supporting data and the reader is 
invited to consult them when prompted. 
"9(ptfiity shocks me. I 'm a scientist.''' 
Harrison Ford (b. 1942), as Indiana Jones in 
The temple of doom, 1984 
CHAPTER 1 ADDITIONAL THEORY 
1.1. Raman spectroscopy 
1.1.1. Light scattering 
A molecular chemical bond is surrounded by a more or less polarisable "cloud" of electron. 
This cloud can be pushed and distorted from its equilibrium position by electric fields. The 
polarizability of the electron cloud is characterized by the ease with which it can be distorted 
by external electric fields. 
As light is an electromagnetic radiation that consists of oscillating electric and magnetic fields, 
it can affect an electron cloud and make it oscillate, from its original equilibrium position to a 
higher vibrational level and back [Pelletier, 1999]. When the light causes a distortion in the 
electron cloud, electrons are excited to a virtual energy state. This phenomenon is brief and, as 
light is "liberated", the electron cloud relaxes back. It can relax to its original state, in an 
elastic manner, producing what is called Rayleigh light scattering. Observed light has then the 
same energy level than excitation light. The electron cloud can also relax back to a different 
energy level than it started from, producing Raman light scattering. In fact, only a very small 
portion of the incident light will be shifted and produce a Raman scattering [Pelletier, 1999; 
Schmitt, 2006; Smith, 2005;]. 
Moreover, two types of Raman 
scattering can occur. The excited 
electron can relax to a higher 
vibrational level than it started from, or 
to a lower level. The three types of 
electron excitation and relaxation are 
illustrated in Figure 1.1 [taken from 
Figure 1.1: Vibrational energy states change 
Smith, 2005]. during scattering processes 
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When energy is transferred from the light to the molecule (relaxation to higher vibrational 
level), Stokes Raman shift occurs and red-shifted light is observed; if it is transferred from the 
molecule to the light (relaxation to a lower vibrational level), anti-Stokes Raman shift occurs, 
producing blue-shifted light. When mention of Raman scattering is made, it is generally 
assumed that it refers to Stokes Raman scattering [Schmitt, 2006; Smith, 2005; Bakeev, 2005]. 
The difference in absolute 
energy of the emitted and 
observed light is equal for 
Stokes and anti-Stokes Raman 
shift, but the intensity of the 
scattering differs. The latter 
phenomenon is much weaker 
than the former, and is 
increasingly weaker with 
increasing vibration frequency. 
This means that the spectrum is 
symmetric, with the axis 
corresponding to the emitted 
light's wavelength, but that the 
symmetric portions are not 
mirror images of one another 
due to the intensity difference 
between the Stokes and the anti-
Stokes portions [Bakeev, 2005; 
Schmitt, 2006; Smith, 2005]. 
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These observations are well illustrated in Figure 1.2 [taken from Bakeev, 2005], while a 
dramatic example of the relative weakness of anti-Stokes scattering is shown in Figure 1.3 
[taken from Smith, 2005]. Note should be taken that, to enable comparison of spectrum 
independently of the incident light's wavelength, the latter is usually labelled as being zero 
[Bakeev, 2005]. 
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1.1.2. Raman active molecules and interferences 
Raman scattering can be observed with both symmetric and non-symmetric and for both polar 
and non-polar molecules, although a stronger scattering will generally be observed with non 
polar symmetric molecules. This is because Raman scattering is associated with the change in 
the molecule's polarizability when its electrons are excited by the emitted light [Bakeev, 2005; 
Smith, 2005]. If a strong polar center exists in the molecule, it will be much less likely for the 
electron cloud to be disturbed by incoming light, because it is "held back" by the polar center. 
If no such center exists in the molecule, the electron cloud is more "free" to be moved around. 
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Hence, polar and asymmetric molecules are less likely to express Raman scattering in a strong 
manner and, in general, asymmetric vibrations will be more intense in IR then in Raman 
scattering [Bakeev, 2005; Smith, 2005]. Moreover, if a molecule has a center of symmetry, the 
mutual exclusion rule stipulates that any of its vibrations can either be Raman active or be IR 
active, but not both [Smith, 2005]. 
In general, compounds with double or triple bonds, different isomers, sulphur-containing and 
symmetric species will lead in strong Raman scattering. For example, strong Raman scatters 
are observed with the following molecules: -C-C-, -C=C-, -C=C-, C=N, -N=N- and -S-S-, -C-
S-, while a weak signal will be observed from molecules such as -O-H. Thus, one advantage 
of the Raman spectrum is that it is not contaminated by polar solvent signal, such as water's 
[Bakeev, 2005; Pelletier, 1999]. 
Also, note should be taken that, in solid samples, it is possible to observe vibration on a 
Raman spectra although only non-Raman active molecules are present. This happens when 
light radiation interacts with a lattice and induces vibrations through it [Smith, 2005]. 
One of the biggest spectral contaminant is fluorescence. This phenomenon is caused when 
electrons are excited to high virtual energy level and cascade down this level to the lower 
excited level. After a period of time, the electrons relax back to the equilibrium energy level, 
emitting light. Just like with Raman scattering, the electron cloud can relax back to its original 
position or to a higher or lower energy level, illustrated in Figure 1.4 [taken from Pelletier, 
1999]. 
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figure 5.1 Energy level diagram illustrating changes that occur in IR, normal Raman, re-ionance Raman, 
and fluorescence. Notation on the figure stands for Rayteigh scattering {R>, Stokes Raman scattering <S), 
and Mti-Stokes- Raman scattering (A). Reprinted from f erraro el at C2Q035' with permission from Elsevier. 
Figure 1.4: Energy level diagram illustrating fluorescence 
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This light emission process does not follow the selection rules of Raman scattering. While 
most materials do not fluoresce appreciably, those who do, however, "absorb light strongly 
and convert nearly every absorbed photon into fluorescence photon" [Pelletier, 1999]. 
Fluorescence affects negatively the quality of Raman spectra and can introduce a significant 
challenge in the analysis of certain type of substance or samples, such as highly colored 
materials or samples contained in green glass bottles [Bakeev, 2005; Heinz, 2007; 
Mukhopadhyay, 2007; Smith, 2005]. Fluorescence often looks like a slowly changing baseline 
on a Raman spectra, with features much broader than Raman bands [Pelletier, 1999]. 
"Because the Raman effect is many orders of magnitude less intense than fluorescence, the 
fluorescence from even trace impurities will overwhelm the Raman signal" [Mukhopadhyay, 
2007]. In trying to predict whether a sample will fluoresce, not much can be done. It is known 
that sample color is not a reliable guide. Liquids can also produce fluorescence [Smith, 2005]. 
Fortunately, solutions have been found to overcome this problem. Given that fluorescence 
interference increases with shorter laser wavelengths, using a 785 nm laser will reduce the 
fluorescence effect. Although using such a laser also reduces the strength of the Raman effect, 
this is not much of a problem, as nowadays' high sensitivity CCD detectors are readily 
available [Bakeev, 2005; Mukhopadhyay, 2007; Smith, 2005]. It is reported that at "633 nm 
perhaps 10 % of samples fluoresce, but [that] this drops to 5% at 785-815 nm and 1-2 % at 
1064 nm"[Sasic, 2008]. 
Using FT-Raman with NIR laser source can also significantly reduce fluorescence but this 
technique comes with its own disadvantaged, as discussed later [Smith, 2005]. 
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Also, photo-bleaching could be a viable solution to 
fluorescence if the degradation of part of the sample is 
not a concern. Photo-bleaching is achieved by exposing 
the sample to the laser light for a period of time, varying 
from a few seconds to several hours, before actually 
taking the Raman scattering measurement. This 
exposition causes the fluorescent compound to 
selectively absorb more energy and consequently 
thermodegrade, hence ceasing to emit fluorescence. This 
technique can be a good way to solve the problem, as 
illustrated by Raman spectra presented in Figure 1.5 
[adapted from www.spectroscopyeurope.com], if the 
fluorescent compound is a contaminant of the sample 
and is of no interest in the analysis [Smith, 2005; 
www.spectroscopyeurope.com]. This "quenching" 
phenomenon happens because fluorescence is not the 
only mechanism that can allow an excited electron cloud Figure 1 5* Photo-bleachine 
to relax back to its ground energy level. result example 
Other mechanism exists that do not interfere with Raman spectrum, as they are non-radiative. 
However, some of them are irreversibly destructive to the molecule and, no matter how well 
fluorescence competes with these other less probable mechanisms, in the long term, the 
fluorescent molecules will be destroyed because of the irreversibility of the alternative 
mechanisms. 
Other techniques, not covered here, can be used to reduce the interference of fluorescence. 
1.1.3. Measuring system 
Light scattering is observed in Raman spectroscopy thanks to a spectroscopic system that 
comprises an excitation source (laser), light collection and filtering system (probe, filters and 
spectroscope) and a detector (often a charge-coupled device - CCD). The usual optical path of 
the light in a Raman spectroscopy probe is illustrated in Figure 1.6 [taken from Bakeev, 2005]. 
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Figure 1.7: Schema of Raman spectroscopy 
Excitation source 
The excitation source is the laser, which is most commonly chosen to be in the visible light 
region (488 - 632.8 nm), because it combines useful advantages over other wavelength laser, 
such as being readily available, compact, less expensive and less of a safety hazard [Smith, 
2005]. 
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NIR laser, 785 or 1064 nm, are also quite common. The use of the latter allows significant 
reduction of fluorescence since, at 1064 nm, "few molecules have excited states low enough 
in energy to give fluorescence" [Smith, 2005] [Sasic , 2008]. This allows reducing further the 
need for sample preparation because possible fluorescence interference of sample container 
such as bottles is reduced when compared to visible Raman spectroscopy. However, since 
most samples do not absorb NIR radiation as efficiently as visible radiation, high laser power 
must be used, which in turn causes increased tendency to sample thermal degradation [Bakeev, 
2005; Sasic , 2008; Smith, 2005]. 
Overall, the key features of visible lasers are their better signal-to-noise ratio, cheaper 
detectors and increased occurrence of fluorescence. The key features of NIR lasers are the 
weaker Raman signal obtained, more expensive detectors required, and decreased sensitivity 
and background, including fluorescence [Sasic , 2008]. 
Sampling options 
The sampling device may vary depending on the application, the most useful for a potential 
process applications being fibre optic-based probe or sample chamber. 
The use of fibre optics enables to separate the sampling head from the spectrometer, which 
can turn out to be a great advantage for on-line analysis. This means that materials of great 
physical sizes, or that are hazardous to handle, can be analyzed by spectrometry by simply 
pointing the probe at the sample. However, the use of fibre optic can results in the increase of 
interference, since the laser light can also excite the fibre optic itself, especially if the sample 
analyzed has weak Raman scattering or if a large length of cable is used. Fortunately, simple 
fibre optics arrangement, such has using multi-mode cables, can usually solve this potential 
problem [Bakeev, 2005; Sasic , 2008; Smith, 2005]. 
Light collection, filtering and separing system 
The filtering device is the part of the spectrometer that removes the Rayleigh scattered light 
(same frequency as the laser) from the collected signal, prior to signal detection. Because the 
laser wavelength is many orders of magnitude greater than the Raman signal, it must be 
removed. In order to achieve this, 2 or 3 monochromators can be used, the first one separating 
the frequency shifted Raman scattering and the second increasing the dispersion to separate 
Raman peaks. However, nowadays, notch filters are the devices mostly used in Raman 
_ _ _ _j^L 
spectroscopic systems, because they are small and efficient. These filters are designed to 
absorb light at the frequency of the laser, usually within 200 cm"1 or better of the laser 
wavelength. Edge filters, which remove all light outside of the Stokes Raman scattering 
portion, are also in use [Bakeev, 2005; Smith, 2005]. 
Light exiting the filter is usually focused on a monochromator that separates the different 
energies of Raman scattering [Bakeev, 2005; Smith, 2005]. This separation of the light 
according to wavenumbers results in the appearance of the Raman spectrum. It can be done in 
two ways: dispersive spectrograph and non-dispersive Fourier-Transform (FT) spectrometer. 
In the dispersive system, gratings are used to diffract the scattered light because they are 
sensitive (gives high signal-to-noise ratio) and do not require high laser power or moving parts. 
Non-dispersive systems, which are almost always associated with FT modulation of the signal, 
do not imply physical separation of the wavenumber; the light passes through a "scanning 
interferometer to generate a temporal signal on a single detector. The Fourier transform of that 
temporal signal corresponds to the wavelength spectrum of the input light." They are 
extremely precise for wavenumbers but are significantly less sensitive than dispersive systems 
[Sasic, 2008]. 
Detector 
After having been separated, the radiation is focussed onto a detector. This detector, most 
commonly a silicon-based CCD, is the part that allows the fast, full-spectrum measurement of 
the Raman signal. The use of CCD allows to reduce the number of moving parts of the whole 
Raman system, which in turn contributes to increase instrument robustness and stability 
[Bakeev, 2005; Sasic , 2008; Smith, 2005]. "CCD cameras consist of two-dimensional arrays 
of pixels that each can be considered as an independent detector. The horizontal pixels are 
calibrated so as to correspond to the wavenumber axis, while the vertical pixels actually 
measure the strength of the Raman signal." The whole forms an image of the Raman signal 
that is converted into a spectrum [Sasic , 2008]. 
With FT-Raman spectrometers and 1064-nm laser, the detector is generally a germanium (Ge) 
or an Indium Gallium Arsenide (InGaAs) detector. "Ge detectors are more sensitive but [...] 
requirfe] constant cooling with liquid N2. InGaAs detectors perform adequately with good 
linearity but are not as sensitive as Ge detector" [Sasic , 2008]. 
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1.1.4. General applications 
"Raman spectroscopy is one of the few analytical techniques which can positively identify and 
characterize both elements and molecules" [Smith, 2005]. Therefore, it has a wide range of 
possible applications; it may be used in any field which requires assessing the presence or 
absence of a given species, quantifying it and/or identifying unknown substance or physical 
form of elements, etc. 
Given this variety of possible applications, it is not surprising to know that Raman 
spectroscopy is used in many scientific and industrial fields, including biomedical, materials, 
geology, gemology, archeology and marine science as well as chemical, polymer, 
pharmaceutical, medical, semiconductor, ceramic and environmental industries [Bakeev, 2005; 
Smith, 2005; Schmitt, 2006]. 
For example, Raman spectroscopy can be used for non-contact reaction monitoring in 
bioreactors or to monitor the advancement of many kinds of reaction, such as polymerization, 
chlorination, iodination, calcination, hydrolysis, etc. It can also be used as a quality-
monitoring tool, in-line or off-line. One may think of examples such as monitoring the 
blending of raw materials or identifying the presence of important species in the monitored 
blend [Mukhopadhyay, 2007]. It is also possible to use Raman spectroscopy to analyse the 
physical form or state of a substance, the orientation, stress or strain on a material. 
A review of published literature lead to the identification of many applications actually 
studied for Raman spectroscopy. Results that are not related with the pharmaceutical field are 
summarized and presented in Table 1.1. 
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CATEGORY OF 
APPLICATIONS 
Biology and 
microbiology 
[Edwards, 2007; 
Pearman, 2007; 
Pelletier, 1999; 
Tripathi, 2008; 
Villar, 2005] 
Biomedical 
[Ko, 2006; Malini, 
2006; Matousek, 2006; 
Zenone, 2006] 
Safety and 
environment 
[Elliason, 2007; 
Schmitt, 2006; 
Heathcote, 2005] 
Material sciences 
[Elizalde, 2005; 
Salpin, 2006; Smith, 
2005; Schmitt, 2006; 
Stanimirovic, 2005; 
Tanaka, 2006; 
Whitney, 2007; Wu, 
2007] 
Chemistry 
[Schmitt, 2006] 
Physics 
[Schmitt, 2006] 
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SPECIFIC APPLICATIONS 
• Waterborne pathogen detection. 
• Study of extremophile microorganism 
survival strategies and survival-specific 
biomolecule production. 
• Study of chemical communication of 
microorganism. 
• Study of peptides and proteins structure. 
• Detection of tumoral, cancerous and/or 
malign tissue to help early cancer detection 
or cancer-related diagnosis and follow-up. 
• Noninvasive Raman spectroscopy of human 
tissue in vivo and ex vivo, as possible 
diagnosis tool. 
• Detection of nanomolar concentrations of 
water pollutants. 
• Detection of concealed liquid explosives. 
• Classification of rocks and identification of 
mineral phases, such as meteorites 
characterization. 
• Study of molecular orientation distributions 
in polymers. 
• Identification of dyes and quantification of 
dye mixes. 
• Local strain and stress characterization in 
materials. 
• Monitoring of emulsion polymerization 
• Profiling of crystal structure. 
• Identification and characterization of 
elemental carbon. 
• Study and describe chemical bonds that are 
currently not well understood. 
• Investigate excited states of 
photochemically active systems. 
• Observation of low-wavenumber excitations 
of solids, such as acoustical phonons. 
• Characterization of flame profile in 
combustion processes. 
>y applications 
MAIN CONCLUSIONS 
Raman spectroscopy can 
now be used in a non-
destructive manner even 
with organic matter and 
living organism. 
The studied approaches 
pave the way to new 
diagnosis and probing 
tools for modern day 
medicine. 
Raman spectroscopy has 
the potential to be a great 
and versatile handheld 
device that can be use in a 
wide range of 
environmental context and 
by just about anyone. 
Raman spectroscopy is of 
central importance for the 
specification and structural 
analysis of materials. 
"Raman spectroscopy 
represents one of the most 
useful tools for obtaining 
information about 
structure and properties of 
molecules" [Schmitt, 
2006]. 
Specialized Raman 
spectroscopy techniques 
bring new ways of pushing 
further the limit of human 
knowledge and 
comprehension of nature. 
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1.1.5. Pharmaceutical solid dose applications 
"The advantages of Raman spectroscopy to the pharmaceutical community come largely from 
the ease of use, minimal sample handling and strong differences in relative scattering 
strengths of packaging materials, tablet excipients and the active agents" [Smith, 2005]. With 
the possibility of using fibre optics, these strengths may well be responsible for the usage 
growth observed in the pharmaceutical industry [Bell, 2004; Heinz, 2007; Pelletier, 1999; 
Schmitt, 2006]. 
As the "active drug is often an aromatic-based compound with distinctive Raman spectra 
whilst the other components", including the packaging material, are not as active, the 
possibility to check the sample directly through its packaging "produces tremendous time and 
cost savings" for the pharmaceutical industry, as this field involves a lot of different quality 
control tests [Smith, 2005]. Many studies have proven the great potential of Raman 
spectroscopy to adequately analyse and quantify pharmaceuticals, when combined with 
multivariate data analysis methods (MVDA). Moreover, being able to study the sample 
through its packaging, as illustrated in Figure 1.8 [taken from Smith, 2005], is hence a great 
advantage of Raman spectroscopy [Bell, 2004; Mazurek , 2006; Pelletier, 1999; Szostak, 2002; 
Szostak, 2004]. 
In the pharmaceutical field, a lot of different applications of Raman spectroscopy have been 
identified, especially in the last few years. Apart from API and excipients identification and 
quantification, studies mention, among other, the possibility of: 
• determining the tablet crushing strength, particle shape, form and/or diameter; 
. evaluating the drug hydrate state in fluid bed drying; 
• monitoring powder blends; 
• in-process monitoring and controlling; 
• helping process and formulation development [Bell, 2004; Hausman , 2004; Heinz, 
2007; Schmitt, 2006;]. 
Also, "the active component itself can have variable properties dependent on the physical 
form or crystallinity", which can often be differentiated and studied successfully with Raman 
spectroscopy [Smith, 2005]. 
Figure 1.8: Raman spectra illustrating the possibility of sampling through packaging 
Even though, according to Mazurek et al (2006), not a good deal of studies has been published 
on the application of Raman spectroscopy to the quantification of an API in a tablet, and even 
less for ones in concentration in lower range, quite a good amount of those could be found and 
a summary of some published studies is reported in Table 1.2. 
In light of the studies surveyed, it seems that Raman spectroscopy has a great potential for the 
study of pharmaceutical solid doses. It has been shown to allow identification and 
quantification of various API and excipient, both in high and low concentration, with a rather 
impressive precision. The main difficulties reported regarding such an application concern 
principally the care that must be taken in optimizing the spectrometer and optics set-up and 
developing a representative calibration set for model design. Once these technical difficulties 
have been addressed, the elaboration of the method for identification and quantification of 
compounds seems to be reported as straightforward. Results obtained are considered both 
precise and repeatable, two features of great importance in the pharmaceutical field. 
The many real-life application potential of Raman spectroscopy in the monitoring of tablets 
has been demonstrated numerous times and studies continue to be published quite regularly on 
the subject. 
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Table 1.2: Summary of studies reported on pharmaceutical solid dose forms 
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Captopril 
(4.2 %w/w) and 
Prednisolone 
(16.7 %w/w) 
[Mazurek, 2006] 
Ambroxol 
15 %w/w 
[Szostak, 2004] 
Ambroxol 
[Hwang, 2005] 
MDMA in 3-
component 
tablets 
[Bell, 2004] 
Acetylsalicylic 
acid and 
Acetaminophen 
[Szostak, 2002] 
Magnesium 
Stearate 
[Aguirre-Mendez, 
2007] 
Ratinidine HC1 
[Taylo, 2000] 
. FTRS, 1064 nm laser; 
. PCR and PLS treatment, 
5 PCs; 
• 28 calibration samples. 
. FTRS; 
. PLS treatment, 5 PCs; 
• 28 calibration samples. 
• Dispersive, 785 nm; 
. PLS treatment, 3 PCs; 
• 20 calibration samples. 
• Raman, 785 nm laser; 
• Univariate calibration 
model; 
• average 64 
points/tablets. 
. FTRS, 1064 nm laser; 
• 16 and 2 cm1 resolution; 
. PCR and PLS treatment, 
3 PCs; 
• 28 calibration samples. 
• Dispersive, 785 nm 
. FTRS, 1064 nm, 800mW 
• Quantitative model based on 
calibration system in which 
some additives have not been 
used can result in poor 
model 
• Weak Raman signal of the 
samples; 
. High RSEP for low-
concentration constituents. 
• Quantitative model based on 
calibration system in which 
some additives have not been 
used can result in poor 
model 
• Choosing an adequate 
number of grid points to scan 
per tablet was reported to be 
a challenge 
• Determine optimal 
spectrometer and model 
conditions, particularly for 
preparation with low active 
concentration. 
• None reported 
• Obtaining spectra 
representative of the bulk 
MMNCONCI.IMONS 
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• RSEPcaptopril 
= 2.75 % 
• RSEPprednisolone 
= 3.24 % 
. RSEP varies 
between 1.9 and 
2.7 % 
. SECV = 0.30to 
0.36 % 
• SD of unkowns = 
0.15 % 
. R2= 0.988 
. RMS = 1 . 1 % 
• Analysis of tablets 
using multiple-point 
averaged spectrum 
can give data with 
low sampling error 
. Best RSEP = 0.99 % 
• LOD of method is 
0.1 %w/wfor 
powders 
• LOD of method is 
1% of total tablet 
weight 
1.2. Multivariate Data Analysis and modeling 
Raman spectroscopy results in an amount of data that can rapidly become overwhelming. 
Even though "univariate analysis is the simplest mathematical approach towards interpreting 
Raman spectroscopic data" [McGoverin, 2008], "multivariate methods [...] that can extract 
qualitative and quantitative information from the whole spectrum [are often] employed. In 
[such] analysis, the covariance between the spectral data and known concentration data is 
P-23 
"Multivariate methods use the intensity variables at several selected wavenumbers or entire 
regions of the spectra for analysis" [McGoverin, 2008]. "In almost every case, [this] approach 
will be superior to the univariate measurement in both robustness and limit of 
[quantification]" [Sasic, 2008], because "complex mixtures often have complicated Raman 
spectra, in which peaks attributable to the various components overlap[, causing] univariate 
analysis [to be] ineffective" [McGoverin, 2008]. 
"There are a number of multivariate techniques that take into account the change of the entire 
spectrum. They can "be broadly classified as either qualitative or quantitative. Qualitative 
methods identify or group samples on the basis of Raman spectral features, for which 
principal components analysis (PCA), discriminant functions and clustering techniques may 
be used. Quantitative methods measure the concentrations or physical properties of complex 
mixtures" [McGoverin, 2008]. They typically employ principal components regression (PCR), 
partial least square (PLS) and multiple linear regression (MLR) [Hausman, 2005; McGoverin, 
2008]. 
1.2.1. Principal Component Analysis 
"PCA is a data reduction technique in which new, uncorrected variables are formed from 
linear combinations of the original variables. The new variables (principal components - PC) 
are formed such that the maximum amount of variance is accounted for" [McGoverin, 
2008].In this technique, the user must choose a number of PCs to use that is much less than 
the original number of variables. "This necessarily involves ignoring a small fraction of the 
variation in the original X-data [...]. In practice, the choice of an optimal number of PCs to 
retain in the PCA model is a rather subjective process, which balances the need to explain as 
much of the original data as possible with the need to avoid incorporating too much noise into 
the PCA data representation (overfitting)" [Bakeev, 2005]. Note should be taken that PCA is 
not a regression method. 
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1.2.2. Multivariate regression 
"Principal component regression (PCR) is simply an extension of the PCA data compression 
method" [Bakeev, 2005]. "[It] uses significant principal components selected from a PCA on 
the spectral data as predictors [...] in a least squares regression" [McGoverin, 2008]. "The 
main advantage of PCR over [other similar methods] is that it accounts for covariance 
between different X-variables, thus avoiding any potential problems in the model computation 
mathematics, and removing the 'burden' on the user to choose variables that are sufficiently 
independent of one another". Also, it is a flexible method and do not require knowledge of 
anything more than the single property of interest for the calibration samples [Bakeev, 2005]. 
However, "one must be careful to avoid the temptation of overfitting the PCR model[, ] [...] 
through the use of too many PCs, thus adding unwanted noise to the model and making the 
model more sensitive to unforeseen disturbances" [Bakeev, 2005]. 
Partial least square - also called projection to latent space - (PLS) analysis "can be used to 
obtain qualitative and quantitative information from spectra that are usually difficult to obtain 
using traditional univariate methods. It can extract information from regions or entire spectra 
and is particularly useful for coping with cross-correlated and noisy data" [Virtanen, 2008]. It 
"is a highly utilized regression tool in the chemometrics toolbox, and has been successfully 
used for many process analytical applications" [Bakeev, 2005]. It "is a regression method, 
with an x matrix and y vector (or matrix [for several y variables]). [...] It is, like PCR, a 
projection method and works in a similar manner. The difference is that while PCR captures 
as much of the variation in x as possible in each component, PLS calculates components that 
both capture the variation in x and correlates with the variation in y" [Svensson, 1999] 
[McGoverin, 2008]. "Because Y-data are used in the data compression step, it is often 
possible to build PLS models that are simpler [...], yet just as effective as more complex PCR 
models built from the same calibration data. [...] [As] simpler models are more stable over 
time and easier to maintain", it is a great advantage of PLS over PCR. A "potential 
disadvantage of PLS over PCR is that there is a higher potential to overfit the model through 
the use of too many PLS factors, especially if the Y-data are rather noisy" [Bakeev, 2005]. 
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1.2.3. Model verification 
Model verification is most often referred to as "validation". 
A good validation process of the model will allow the user to make sure that the model 
developed does not suffer from over- or underfitting and that it is accurate when applied to 
data that were not used to build it [Bakeev, 2005]. Validation will allow assessing the 
accuracy of the analysis, and may be done in two ways: test set validation and cross-validation. 
When sampling is made for model calibration, thoughts should be given to the validation test 
set. Whenever possible, extra samples should be taken in order to obtain a validation test set 
that is representative of both the calibration set and the future samples that the model is 
intended to treat. If the two data set are gathered correctly, then "there can effectively be only 
one variance component that will differ between them; the sampling variance. This sampling 
variance will comprise those differences between the two data sets that can only be explained 
by the different samplings of n objects, made under conditions which are otherwise as 
identical as possible. This is the essence of the concept of test set validation" [Esbensen, 2004] 
[Brereton, 2003]. 
Once the model has been developed, analyzed, improved and is thought ready to be used, the 
validation test set should be the first sample set to be predicted by the model. Since the 
reference values for the validation test set are known, it is possible to evaluate the model's 
prediction values by comparing it to the known "true" value of the test set; the degree of 
correspondence between both value sets will thus be an assessment of the model's prediction 
strength [Brereton, 2003; Esbensen, 2004]. 
In the case where obtaining a separate validation test set is not possible, a solution exists to 
obtain an estimate of the model's prediction ability: cross validation. While it is not a proper 
validation method in itself, it is still useful 1) as a first estimate of the model's strength during 
its development and/or 2) as a substitute to test set validation when the situation prevents it 
[Brereton, 2003; Esbensen, 2004]. 
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Cross validation is done as follows. While the software is computing the model, it leaves out a 
portion of the calibration set from the calculations, builds the model with the remaining 
samples, uses the model to predict the left-out's values, computes the difference between the 
predicted and the real values and then reintegrates the left-out samples in the calculations, 
leaving out the next data "block" or "segment", and so on. It does this procedure until all data 
segments have been left out once. Finally, the model is calculated with all the samples and the 
results of the successive predictions are computed against the actual ("observed") values to 
estimate the sampling variance. The left-out segments can encompass anywhere from 1 to nil 
samples. When each segments includes only one sample - meaning that every sample will be 
left-out once - the cross validation is qualified of full; otherwise it is called a segmented cross 
validation [Brereton, 2003; Esbensen, 2004]. 
The crucial difference between test set and cross validation is that in the latter, there never is 
an "independent new realization of the target population sampling[, only] [...] an internal 
permutation of the same calibration set", meaning that this method represents more the 
internal model stability then the future prediction error. 
When doing a cross validation, the analyst has to adequately choose the number of samples 
that will constitute each segments. It should represent a realistic simulation of an appropriate 
re-sampling of the target population. As such, Esbensen [2004] recommends the use of 
segments representing 10% of the total sample number. The main drawback of doing so is that 
the sub-models will be based on fewer samples, but it has the great advantage of properly 
simulating the sample variance. 
Also, systematically using the full cross validation is a common practice that should albeit be 
avoided. It is indeed very "unlikely that one left-out sample alone will induce any significant 
sampling variance in any well-structured model (no outliers left in, no sub-groupings, etc)" 
[Esbensen, 2004]. As such, full cross validation is beneficial only when really few samples are 
available, in which case a segmented approach would imply sub-models based on too few 
samples [Brereton, 2003]. 
Finally, cross validation is also useful as a diagnosis tool to select the number of components 
that is ideal for the model being developed. Indeed, "cross-validated errors normally reach a 
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minimum as the correct number of components are found and then increase afterwards. This is 
because later components really represent noise and not systematic information in the data" 
[Brereton, 2003] [Esbensen, 2004]. 
"The common error statistics for quantification analyses are root mean standard error of cross-
validation (RMSECV) and root mean standard error of prediction (RMSEP). Both error 
statistics are calculated by summing the square of the difference between the predicted and 
actual values and dividing this sum by the number of samples. The square root is taken of the 
resulting value so that the units of the quantified variable are the same as the error statistic" 
[McGoverin, 2008]. 
"'A goal without apian is just a wish!" 
Antoine de Saint-Exupery (1900-1944), unsourced 
CHAPTER 2 DESIGN OF EXPERIMENT 
The present chapter describes the design of experiment that was made to direct the 
experiments. 
The design of experiment was elaborated according to the following statement regarding the 
QbD approach to development. The Critical Quality Attributes (CQA), in this case, was 
considered to be the final method's ability to accurately and precisely replace currently 
approved testing method. 
"Risk assessment and process development experiments [that are part of the QbD approach] 
[...] can lead to an understanding of the linkage and effect of process parameters and material 
attributes on product CQA, and also help identify the variables and their ranges within which 
consistent quality can be achieved. These process parameters and material attributes can thus 
be selected for inclusion in the design space" [US ICH, 2008]. 
2.1. Overall methodology 
The overall project is separated in three sequential phases. The planning of all experiments 
was done as a first phase, in order to optimize the project development efficiency. 
After such planning, the second phase was to develop an MVPM-based PAT method similar 
to protocol currently used by Wyeth / UdeS research group. The development of this method 
implies the elaboration of several MVPM, given that there are several components to quantify 
in the samples. The best-performing predictive models were then selected as a base-case for 
the third phase of the project. This last step consists of studying the effects of varied 
calibration parameters on model performances and drawing conclusions on method 
development protocol. The details of the project outline are schematized in Figure 2.1, where 
the three sections represent the three phases of the project. 
p. 28 
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Figure 2.1: Schematized methodology for project development 
Using the base-case models, selected parameters variation were analyzed regarding their 
effect on the model performance. Those results were used to propose an optimized 
development protocol. 
2.2. Calibration parameters selected 
Calibrating a predictive model requires that many choices be made, each of them being a good 
variation subject for the proposed study. Parameters and variables that can be varied are 
encountered throughout the course of predictive model calibration. They are presented in the 
following sections, organized to outline the main development steps. 
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2.2.1. Preliminary work and protocol establishment 
The calibration span must be chosen first. The decision is made based on several factors, 
including but not limited to, the specifications of the product to be tested, the known 
occurrences of out of specification product samples and previous knowledge of the 
manufacturing process. 
Once the calibration span is established, the number of calibration points selected to cover the 
span must be chosen. Depending on the complexity of the product and the level of confidence 
of the developer regarding tested technology performances, the number of sample points 
prepared varies. 
Moreover, each calibration point must be replicated a certain number of times to insure that all 
possible source of variation is covered. Additional replicates allow better coverage of the 
possible range of future sample variations. Also, when dealing with tablets, an additional 
challenge must be taken into account: any given part of the tablet is not necessarily 
representative of the overall tablet content [Li, 2003]. When the content assay is done with 
wet chemistry, this factor is not a source of signal variation because the whole tablet is 
dissolved, hence allowing the possibility to obtain a value representative of the whole tablet. 
For example, Cournoyer et al, for a 5-ingredients product (2 API and 3 excipients), selected a 
calibration span of 85 - 115 and 0 - 240 % of the claim value for the API. They covered the 
calibration span with 17 calibration points counting each 6 replicates [Cournoyer, 2008]. 
2.2.2. Sample preparation 
Typically, manufacturing of the development samples is based on that of the commercial 
product, to allow the calibration of the predictive model to be based on samples that are as 
representative as possible of those for which the application is intended. 
But even though the manufacturing protocol is based on the large-scale process, many 
sacrifices will have to be made. Equipment sizes that can be used in the laboratory may in 
some cases be very different from that used to manufacture commercial product and their use 
may or may not influence on the final predictive model performances. Moreover, there are 
often several choices of apparatuses available for a single unit operation. The choice of using 
one type over another can be made based on previous knowledge, availability of the 
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2.2.3. Data collection 
In order to obtain a multivariate predictive model that can predict the concentration of a 
sample in a given component, a correlation must be obtained between the response and the 
said concentration. There are two main choices for this correlation: using the experimental 
data of concentration or a reference value. The experimental data is obtained from the protocol 
execution: it is the quantities of each raw material that the analyst reported to have weighted 
and used. The reference value is a reading obtained with a qualified method: it is the method 
currently used to obtain the assay and that is wished to be replaced. 
2.2.4. Modeling 
As discussed in Chapter 1, several modeling techniques can be used to obtain a good 
regression. 
2.3. Design of experiments 
As suggested by the QbD approach for developing a new product - or a new method, in the 
present case - several parameters were chosen to be part of the present study. 
For each parameter, and in order to limit the overall number of tests to be made, two levels 
were chosen, as detailed in Table 2.1. 
A fractional factorial design of experiments (DOE) was used to direct the tests. Such designs 
are "particularly useful in the early stages of experimental work, when there are [...] many 
factors to be investigated. It provides the smallest number of runs with which k factors can be 
studied in a complete factorial design. Consequently, these design are widely used in factor 
screening experiments[, like in this case]" [Montgomery, 2001]. 
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Table 2.1: Parameters and tested levels for the design of experiment 
Press used (Factor A, aka Press) 
Automatic (-1) 
Manual (+1) 
Distribution of calibration points over the calibration span (Factor B, 
aka Distrib.) 
Evenly distributed (+1) 
Concentrated around target (-1) 
Number of calibration points (Factor C, aka NbPts) 
Low (Ca: 6; Mg: 5) (-1) 
High(Ca: 13,Mg:9)(+l) 
Number of replicates within each calibration points (Factor F, aka 
NbRep.) 
Low (5) (-1) 
High (10) (+1) 
Use of commercial sample for model calibration (Factor E, aka Prod.) 
Present (+1) 
Absent (-1) 
Calibration algorithm used (Factor D, aka Algo) 
PCR(-l) 
PLS (+1) 
Reference data used for modeling (Factor G, aka Meas.) 
Reference method value (+1) 
Experimental manufacturing values (-1) 
A resolution of at least IV was desired in order to limit confounding of effects in the screening 
test. The design obtained with generators E=ABC, F=BCD and G=ACD allowed to obtain 
level IV resolution, leading to double interactions being confounding with each other but not 
with the main effects. 
Another useful particularity of such fractional design is that they can be "collapse[d] into 
either a full factorial or a fractional factorial in [many subsets] [...] of the original factors". In 
the event that 3 factors are found to be non significant, the probability of being able to 
transform the design in a full 24 design is high, because 28 of the 35 subsets of four factors are 
not part of the design's defining relation [Montgomery, 2001] and can therefore be projected 
into a full fractional design. Because of this possibility and the difficulty of obtaining 
independent data set, no replicates of the design were planned. 
The design was obtained with the software Statistica, from StatSoft, and is presented in Table 
2.2, along with the confusions in Table 2.3. In this design of experiment, each run represents a 
different predictive model, elaborated with the data corresponding to the levels of the factors 
_ - - - _ Ei.33 
corresponding to the run number. For example, Run 1 represents a predictive model that was 
calibrated with the PCR technique, based on data collected from samples manufactured with 
the automatic press, covering unevenly-distributed calibration points containing each 
10 replicates, without the use of commercial samples and based on the use of Y data obtained 
from reference method. 
Table 2.2: 27"3rv 1/8 fractional factorial design of experiment 
RUN 
# 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
A 
auto 
man 
auto 
man 
auto 
man 
auto 
man 
auto 
man 
auto 
man 
auto 
man 
auto 
man 
B 
cone 
cone 
even 
even 
cone 
cone 
even 
even 
cone 
cone 
even 
even 
cone 
cone 
even 
even 
C 
6(5) 
6(5) 
6(5) 
6(5) 
13(9) 
13(9) 
13(9) 
13(9) 
6(5) 
6(5) 
6(5) 
6(5) 
13(9) 
13(9) 
13(9) 
13(9) 
FACTORS 
D 
PCR 
PCR 
PCR 
PCR 
PCR 
PCR 
PCR 
PCR 
PLS 
PLS 
PLS 
PLS 
PLS 
PLS 
PLS 
PLS 
K 
abs 
pres 
pres 
abs 
pres 
abs 
abs 
pres 
abs 
pres 
pres 
abs 
pres 
abs 
abs 
pres 
1' 
5 
5 
10 
10 
10 
10 
5 
5 
10 
10 
5 
5 
5 
5 
10 
10 
c; 
theo 
ref 
theo 
ref 
ref 
theo 
ref 
theo 
ref 
theo 
ref 
theo 
theo 
ref 
theo 
ref 
* Number in parenthesis denotes factor associated with Magnesium models 
Table 2.3: Confusions in design of experiment 
EFFECT CONFOUNDED WITH 
A 
B 
C 
D 
E 
F 
G 
AB 
AC 
AD 
AE 
AF 
AG 
BD 
ABD 
BCE 
ACE 
ABE 
ACG 
ABC 
ABG 
ABF 
CE 
BE 
CG 
BC 
BG 
BF 
CF 
ACF 
BFG 
AFG 
ADG 
AEF 
ADF 
ADE 
ACD 
FG 
DG 
EF 
DF 
DE 
CD 
EG 
AEG 
CDG 
CDF 
BDF 
BCF 
BDG 
BCD 
BDE 
BCG 
DEF 
DEG 
EFG 
BEG 
CFG 
CEG 
CEF 
BEF CDE DFG 
Chapter 2. Design_of experiment^ 
In addition to the factors presented in Table 2.2, another will be tested. The manufactured 
batch size of each sample preparation is a factor of importance that can either speed the 
manufacturing process or multiply its length. Testing several batch volumes and the effect its 
change has on model performance could hence open great opportunities for method 
optimization. Including it in the design of experiment increased exaggeratedly the number of 
required runs since more than two levels are to be tested and it multiplied the number of 
samples to be analyzed beyond any achievable limits. It was hence decided to test the effect of 
this factor in another manner. Three (3) additional batch sizes of samples will be prepared, 
according to commercial product raw material concentration, to assess whether the prediction 
of a good-performing predictive model is affected by the factor. 
2.4. Analysis of effect 
The design of experiment will generate results that will be used to determine the effect of each 
factor and their interactions, on the predictive model performances. In order to proceed to 
such analysis of effect, a response must be chosen to monitor the effect of the factors. 
The performance of a predictive model is typically assessed through its capacity to accurately 
and precisely predict the concentration of the intended raw material in the intended target. 
Hence, the analysis of effect of the present design will be done using model prediction of 
commercial samples. 
The prediction error of samples will be used as the test response for the analysis of effect. The 
responses will be used to assess the effects of factors on model performances. 
For the batch-volume parameter, prediction error associated to each batch size manufactured 
will be used as a response for hypothesis testing, in the same fashion as previously described 
analysis of effect. The error will be computed based on a full-model prediction 
In order to fulfill the conditions of certain runs of the design of experiment, specific 
concentration combinations with specific calibration point numbers must be available for 
modeling. Those constraints must hence be taken in account when designing the preparation 
protocol. 
Also, the calibration samples need to cover a representative span of concentration variation for 
each raw material that is to be monitored by the multivariate predictive models. Such variation 
is inherent to the product manufacturing and the models must be elaborated in a way that 
allows further work with commercial product. 
Moreover, the concentration of a given raw material should not co-vary with that of any other 
raw material in the sample set, because in that case it would not be possible to know which 
raw material is being predicted by a multivariate predictive model. As such, it is necessary to 
obtain a set of samples in which the concentration of each raw material to monitor is varied to 
a certain span, independently from all other raw materials to be monitored. Ingredients that are 
not to be monitored should also include a certain range of expected normal variation to insure 
model robustness and their concentration should not be linearly correlated to that of any of the 
monitored raw materials. 
Finally, since the ability to monitor components in the chosen product with Raman 
spectroscopy has yet to be demonstrated, there is no way to select a priori the target raw 
material for the research project. A broad approach must hence be chosen to allow the 
elaboration of several preliminary predictive models. From those preliminary models, good-
performing ones will hence be chosen to allow execution of the tests require by the design of 
experiment. 
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Sample composition was hence planned to satisfy those criteria. Concentration points of all 
raw materials to be monitored were decided and then randomly assigned to a powder mix 
number. Small adjustments were then made to each powder mix formulation to insure that 
overall mix was possible (addition of individual raw material quantity added to 100%) and 
absence of linear correlation was verified. 
Theoretical composition of samples to be prepared is detailed in Table 2.4, for each sample, 
in % of composition normally encountered in the selected commercial product. For example, 
82.0 % Vitamin in Mix 1 means that 82.0 % of the product specification value was to be 
added in the mix. Concentration span to be covered by the samples for each raw material were 
chosen according to acceptable limits provided in the product specifications. 
Table 2.4: Theoretical data of calibration sample composition 
VITAMIN MC; C A M3 M4 EXCIPILNT 
claim% claim% claitn% claim% claim% claira% 
Mixl 
Mix 2 
Mix 3 
Mix 4 
Mix 5 
Mix 6 
Mix 7 
Mix 8 
Mix 9 
Mix 10 
Mix 11 
Mix 12 
Mix 13 
Mixl3R 
MixAl 
MixA2 
Mix A3 
Mix A4 
82.0 
110.0 
152.0 
162.0 
192.0 
121.0 
92.0 
72.0 
132.0 
142.0 
172.0 
182.0 
100.0 
100.0 
103.0 
97.8 
106.5 
95 
137.0 
111.0 
78.5 
92.5 
117.5 
72.0 
124.0 
143.5 
150.0 
85.0 
130.5 
105.5 
100.0 
100.0 
101.7 
95.8 
98.0 
103.5 
93.9 
124.5 
77.2 
82.5 
108.8 
135.0 
104.4 
129.7 
114.0 
87.7 
119.2 
72.0 
100.0 
100.0 
101.5 
102.9 
95.9 
98.0 
105.5 
72.0 
78.5 
85.0 
150.0 
124.0 
130.5 
143.5 
117.5 
111.0 
92.5 
137.0 
100.0 
100.0 
98.0 
95.8 
103.5 
101.7 
"8.5 
85.0 
72.0 
117.5 
92.5 
130.5 
143.5 
137.0 
124.0 
150.0 
111.0 
105.5 
100.0 
100.0 
101.7 
95.8 
103.5 
98.0 
85.0 
124.0 
111.0 
72.0 
117.5 
130.5 
78.5 
105.5 
92.5 
137.0 
150.0 
143.5 
100.0 
100.0 
101.7 
95.8 
98.0 
103.5 
This calibration plan allows for minimal correlation for any raw material combination, as 
detailed in Table 2.5. In this table, an excipient is listed because it is another major raw 
material in the formulation and thus the correlation between its concentration and that of 
Calcium was difficult to keep to a minimum. All other excipients were added as fillers in the 
same proportion to one another. The correlation between this group and any other varied raw 
£:...37 
Table 2.5: Correlation between raw materials 
VIT 
Mr; 
C A 
Ml,v3 
MlN.4 
EX('IPIENI"9 
EXCIPIENTS 
()nii:Ri:xt:iPiFjvrs 
VlT 
1 
0.04 
0.11 
0.01 
0.01 
0.25 
0.06 
0.07 
MC 
1 
0.11 
0.12 
0.01 
0.04 
0.21 
0.00 
C,\ 
1 
0.04 
0.07 
0.02 
0.34 
0.34 
MlN. 
3 
1 
0.22 
0.01 
0.02 
0.07 
MlN. 
4 
1 
0.00 
0.09 
0.00 
F.XCIPIOT 
9 
1 
0.06 
0.01 
ExciPiEsr 
5 
1 
0.05 
OlIll.K 
KXCIPIKYIS 
1 
In order to complete sample preparation, a second series of samples was prepared. All 
concentration were kept constant at the level of "Mix 13" described in Table 2.4, but overall 
batch volume was varied. For the first series of samples prepared, volumes were kept constant 
at 3.2 kg of total powder. All preparation volumes are described in Table 2.6, including the 
first series, along with the number of separate batches prepared for each volume and the batch 
volume fraction represented in a single tablet. 
Table 2.6: Preparation volumes of calibration samples 
V()[ IMI-. 
• • 
3200 
16 
6 
1 
II \ 
I'KI 
l( IMS 
i' \nrn 
1 
1 
3 
15 
i Mil i.i \ o n MT. 
1 R \< 1 ION 
l i 
f l 
0.03 
6.25 
16.67 
100 
"He may Be mad, But there's method in his madness. "There nearly always is 
method in madness. It's zufuit drives men mad, Being methodical. * 
Gilbert K. Chesterton (1874-1936), The Fad of the Fisherman,1922 
CHAPTER 3 MATERIAL AND METHOD 
3.1. Sample preparation 
Manufacturing of the development samples was made in such manner as to mimic as closely 
as possible the actual manufacturing method for commercial product. The order of addition of 
each raw material, as well as their relative proportion for those added in several parts, was 
respected as much as possible. 
3.1.1. First series of samples 
Manufacturing of samples was done as follows. Raw materials were weighed and premixes 
were made using a mixer equipped with a beater and 4.5 L bowl. Premixes and additional raw 
materials were then loaded in a Patterson-Kelley Co 16 qt V-blender and agitated for a fixed 
amount of time and rpm, before lubricants were added and mixed for an additional period of 
time. Prepared mixes were transferred in clear plastic bags and stored in opaque white plastic 
buckets in a dedicated room with controlled temperature and humidity. All mixes were 
prepared within a 5 day period. 
Half the quantity of each prepared mixes was compressed the following week over a 2 day 
period, using a Manesty Machines Ltd BB3B double-feeder 27-stations automatic press. Only 
one side of the press was used to feed the process and compress the powder, the free side 
being used for pre-compression with minimum allowable pressure. Punches and matrices for 
the commercial product could not be used to manufacture the development samples because of 
technical incompatibilities but punches and matrices with similar specifications were chosen: 
flat surface with same depth of embossment. Tablet hardness was tested during compression 
process, with a Key International Inc hardness tester HT-500, to ensure even tablet 
manufacturing. Tablets were transferred in clear re-sealable plastic bags and stored in opaque 
white plastic buckets, in a dedicated room with controlled temperature and humidity. 
The other half of each prepared mix was compressed 3 weeks after mix preparation, over a 
5 day period. A Manual Tablet Compaction Machine MTCM-I from GlobePharma Inc was 
used with a constant 1500 psi pressure to obtain tablets. The same punches and matrices as 
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E,3?. 
Mix 
AUTOMATIC PRESS MANUAL PRES*-
AVERAGE 
mg/mm' 
RELATIVE 
STDEV 
AVKRAC.F 
nm/iiim 
RELAIIVL 
STDEV 
"4, 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
13R 
Al 
A2 
A3 
A4 
Average 
1.4474 
1.5252 
1.4012 
1.4288 
1.5072 
1.5540 
1.4732 
1.5196 
1.4952 
1.4128 
1.5084 
1.3960 
1.4708 
N/Av 
1.4680 
1.4688 
1.4528 
1.4624 
1.4701 
1.05 
0.94 
1.14 
1.11 
1.09 
0.95 
1.14 
1.08 
0.93 
1.36 
1.02 
0.92 
1.11 
N/Av 
0.88 
1.20 
1.00 
1.39 
1.08 
1.3516 
1.3356 
1.3232 
1.3000 
1.3327 
1.3324 
1.3296 
1.4084 
1.3082 
1.3081 
1.3120 
1.3030 
1.3011 
1.3338 
1.3224 
1.3360 
1.3274 
1.3368 
1.3279 
1.28 
1.39 
1.43 
1.82 
2.33 
1.74 
1.40 
1.21 
1.87 
1.37 
1.96 
1.14 
2.76 
1.83 
1.58 
1.67 
0.88 
1.39 
1.61 
3.1.2. Second series of samples 
Raw materials were weighed as prescribed by the protocol and transferred in a clear 
scintillation vial or other appropriately sized glass bottles. Homogenization of the powder 
mixes was done by shaking the bottles for a fixed period, both horizontally and vertically, by 
hand. The volume occupied by the powder in the bottle was no more than 50 % of the overall 
available volume to allow sufficient head space for mixing. 
Chapter 3. Material and method 
Samples were compressed following the same protocol as the first series of samples, with the 
manual compression machine. Different punches were used due to the unavailability of the 
original ones. 
3.2. Data collection 
3.2.1. Spectral information 
A selected number of tablets were scanned for each series of tablets. Each scanned tablet was 
placed in a sample bag and individually identified for later reference measurement. 
In order to obtain one sample spectra, 5 tablets of a given batch were scanned one time on the 
middle of each side and the resulting 10 spectra were averaged into one. This process was 
repeated 10 times for each batch. A total of 1 750 development tablets were read, leading to an 
intermediary 3 500 raw spectra that were averaged in a total of 350 spectra. 
Commercial product samples were also used for data collection, with a total of 50 tablets read 
in the same manner, leading to an additional 10 spectra. 
Spectra were acquired over a six week-period with a DXR SmartRaman spectrometric system, 
by ThermoFisher Scientific, equipped with a 780 nm high power laser, 780 nm Rayleigh filter 
and full-range grating (400 lines/mm). The selected spectrograph aperture was a 50 um slit. 
System alignment and calibration was done respectively every 30 and 7 days. Acquisition 
parameters were established as described in Table 3.2 for all spectra acquired. For details 
concerning the effect of each factors as well as reasons for those particular settings, refer to 
Annex 2. 
p - ^ 
Table 3.2: Acquisition parameters used 
VALUE 
PARAMETER 
Acquisition time 
Number of acquisitions 
Laser power 
Beam expander settings 
Spectral range specified 
Spectral resolution 
Focus position 
Background acquisition 
Cosmic Ray threshold 
10 sec 
2 
130 mW 
5 x5 mm 
50-3300 cm"1 
0.964 cm"1 
41 
maximum 30 days-old 
smart backgrounds 
medium 
No automatic corrections were applied to the spectra. Absence of CCD overflow was 
automatically verified by the acquisition software. Raw spectra totalized 3 371 measurement 
points presented on the x-axis as Raman shifts and intensity at each point was reported in 
counts per second (cps) as the y-axis. 
The system's estimated probing capacity for the samples at hand was estimated to be 5 by 
5 by 1 mm , for a total volume of 25 mm . Refer to Annex 3 for details regarding calculations 
for depth of sample probing. When used on the development samples, this volume represents 
approximately 4.6 % of the total 540 mm tablet. When used on commercial samples, it 
represents 1 % of the 2 430 mm tablet. Given that 10 spectra are taken for 5 tablets and then 
averaged into one, the total volume probed is of 250 mm3, which represents 46 % of one 
development unit-doses and 10 % of a commercial unit-dose. 
3.2.2. Reference values 
Reference values were obtained using Wyeth Montreal's reference methods for the 
commercial product, with special instructions to accommodate the development sample's 
special size. 
Five (5) tablets were pooled together to obtain a reference value for Calcium, Magnesium and 
Mineral 3 content. Three (3) of the available groups of samples were tested in this fashion. 
Chapter 3. Material and method 
Six (6) other tablets were pooled together to obtain reference values for Mineral 4 and 
Vitamin content. Four (4) of the available groups of 5 tablets were tested in this fashion, with 
the addition of 1 tablet from the fifth group to each of the four group. This addition was made 
in order to obtain enough powder to allow sample processing according to validated method. 
Mineral content assessment were made using Inductively Coupled Plasma-Optical Emission 
Spectrometry (ICP-OES) and Vitamin assessment was made using High Performance Liquid 
Chromatography (HPLC). 
ICP readings were made with a 735-ES or Vista-Pro ICP-OES system, by Varian, Inc. The 
system was operated according to a USP-compliant fully validated method, by trained analysts. 
HPLC readings were made in reverse phase, using an Alliance® 2695 HPLC, by Waters, with 
an ODS2 column operated according to a USP-compliant fully validated method, by trained 
analysts. 
"Genius is one percent inspiration andninety-nine percent perspiration" 
Thomas Edison (1847-1931), Harper's Monthly, Sept. 1932 
CHAPTER 4 EXPERIMENTAL WORK 
4.1. Sample preparation 
Samples were prepared according to the protocol presented in Chapter 2, Section 2.5. 
Experimental data for minerals, vitamins and one excipient are presented in Table 4.1. 
Samples obtained are illustrated in Figure 4.1. 
Experimental data for samples prepared in the second series were reported to be exactly as 
described in Table 2.4 for "Mix 13" and are also reported in Table 4.1, using a name 
referencing their batch volume. 
Table 4.1: Experimental data for calibration samples composition 
FORMULATION VIT MC; C A M4 M3 EXCIPIENT 9 
DKSCKlFriON HJ/g,lux nig/g,,,,, iiig'gm„ mg/'g,,,,, mg'gm» mg/g. 
Mixl 
Mix 2 
Mix 3 
Mix 4 
Mix 5 
Mix 6 
Mix 7 
Mix 8 
Mix 9 
Mix 10 
Mix 11 
Mix 12 
Mix 13 
Mixl3R 
MixAl 
MixA2 
Mix A3 
Mix A4 
16g 
6g 
lg 
138 
185 
257 
274 
324 
204 
155 
121 
223 
240 
291 
307 
169 
169 
174 
165 
179 
160 
169 
167 
200 
20.6 
16.7 
11.8 
14 
17.7 
10.8 
18.7 
21.6 
22.6 
12.8 
19.7 
15.9 
15.1 
15.1 
15.3 
14.4 
14.7 
15.5 
15.0 
15.0 
14.9 
169.6 
224.9 
139.8 
149.3 
196.7 
243.9 
188.7 
234.6 
206.6 
159 
215.9 
130.4 
181 
181.2 
183.7 
186.1 
173.1 
176.8 
180.3 
180.0 
180.3 
2.5 
1.71 
1.86 
2.02 
3.56 
2.94 
3.09 
3.4 
2.79 
2.64 
2.2 
3.25 
2.38 
2.38 
2.33 
2.27 
2.45 
2.41 
2.36 
2.41 
2.41 
0.45 
0.48 
0.41 
0.67 
0.53 
0.74 
0.82 
0.78 
0.71 
0.86 
0.63 
0.6 
0.57 
0.57 
0.58 
0.55 
0.59 
0.56 
0.57 
0.60 
0.65 
10.4 
15.2 
13.6 
8.8 
14.4 
16 
9.6 
12.9 
11.4 
16.8 
18.4 
17.6 
12.3 
12.3 
12.5 
11.7 
12 
12.6 
12.2 
12.2 
12.0 
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Chapter 4. Experimental work 
Figure 4.1: First manufactured series of samples 
4.2. Data collection 
4.2.1. Spectral information 
All samples were collected as described in Chapter 3. An example of an average spectra 
obtained with the set parameters is given in Figure 4.2. The overlay of all averages for all 
calibration mixes is presented in Figure 4.3. 
700 
"i 1 r 1 1 1 1 r 
3300 3011 2722 2432 2143 1854 1564 1275 986 
Raman shift (cm-1) 
697 407 11J 
Figure 4.2: Average spectra of tablets from mix 13 
p. 45 
Figure 4.3: Overlay of average spectra of tablets from all mixes 
4.2.2. Reference values 
Reference values were collected as described in Chapter 3, Section 3.2. Summarized results 
are reported in Table 4.2 and Table 4.3. Values for Mineral 5 were obtained as part of the 
measurements for Mineral 3 and are also reported, for information only. 
Mix fc • • ui »-*
 
•
-
>
 
^
 
o
o
 
-^
J
 
o
 
•
j>
.
 
1 1 p
 
U
i 
-
i bi
 
o
 
.400 2.0 
Mix fc • • •t> ^ p bo S3 o ji. 1 1 p ui o CD o oo 0.9 
Mix £ • i -s>. w l-> to oo oo to >—* 4* • i p ui -1 N> O .321 0.9 
Mix > • '
 
u
i b i-»
 
to
 
o
o
 
u
i ©
 b\
 
i i p
 
U
i 
o
o
 
M
 
Ul
 
o
 
.316 3.4 
Mix u>
 
o
 3.5 ui
 
U
) to
 
in
 
o
o
 
<
i O
 
"
*.
 
to
 
4*
.
 
0.7 p in
 
N>
 
b O .317 0.0 
Mix to
 305 6.4 Ui
 
to
 
to
 
k>
 
o
 4*
.
 
H
^
 
iu
 
u
>
 
4^
 
^
 
p
 
-
fc.
 
-
>•
 
o
 
.530 3.7 
Mix ^ 283 4.2 o^
 
Lf>
 
tO
 
4*
 
lO
 1°
 
bo
 
o
 b to
 
U
i 2.9 p to
 
00
 
CD
 
O
 
.346 3.0 
Mix o 248 4.2 to
 
b\
 
U
l 
O
N to
 
as
 
p
 
O
O
 
to
 
Ul
 
to
 
0.9 p bo
 
to
 
-
i 4*
.
 
O
 
.250 3.0 
Mix VO
 225 2.6 to
 
to
 
as
 
in
 210. oo
 
o
 
U
l to
 
Ul
 
o
o
 
bo
 
p
 
as
 
o
o
 
-
*
 
CO
 
o
 
.365 2.2 
Mix oo
 5.2 to
 
to
 
O
N 238. oo
 
o
 
U
l 
U
) 
to
 
Ul
 
2.9 o as
 
to
 
oo
 
o
 
.139 2.5 
Mix ^i
 
O
N 5.2 | oo 4^ <1 VO b o as to bo Ul b o N3 ^ O .419 1.3 
Mix OS
 
to
 
©
 bo
 
p
 
bo
 
as
 
249, U)
 
o
 
U
l to
 
to
 
0.5 o u>
 
4*
.
 
en
 
o
 
.140 2.0 
Mix Ul
 
to
 
U
l 
^
 
as
 
*
.
 
to
 
o
 
•
*
.
 
o
 U>
 
u
>
 
o
 
to
 
p
 
U
l 4*
.
 
-
*
 
p
 
00
 
2.0 
Mix 4^
 
272 4.9 OJ
 
so
 
b Ul
 
to
 
4^
 
o
 
U
l 
,
_
,
 
V
O
 
p
 
O
N
 
O
S
 
-
*
 
-
*
 
o
 
.447 3.0 
Mix U)
 
to
 
O
S 4.6 ~ bo
 
to
 
144. as
 
o
 
U
l 
_
 
bo
 
o
 2.8 o J*.
 
N>
 
^
 
O
 
.310 2.0 
Mix to
 
o
o
 
2.2 OS
 
4^
 
1-
1 | 230, Ul o U> _ as 2.5 o 4^ 00 4*.
 
-
1 
O
 
.334 1.0 
Mix 1—4
 
U
l 5.8 to
 
o
 
^
 b\
 
4^
 
as
 
>—
 
1-
1 
to
 
4*
 
3.3 o 4^
 
<
1 O
 00
 
o
 
.223 2.0 
1 
£ 
*
 
@
 
s 
>
 
5p
-
 
w
 
1 
>
 
-^
 
&3
 
I
 
>
 
3 
>
 
er
a 
5 
^
 
S3
 
s 
>
 
5?
 
&3
 
VITA 1 S o > 2 *».
 
2 w 
•
 
H ST
 
a 85
 3 ffi < 5"
 
re
 3s
 
o
 
Si
 
es
 
a"
 
»
 
O*
 
S3
 
t«
 
&9
 I S" in = PS 
n
 
re
 
4^
 
tn
 
x
 3*
 
o
 
7T
"
 
Table 4.3: Mean reference values for calibration samples - manual press 
Mixl 
Mix 2 
Mix 3 
Mix 4 
Mix 5 
Mix 6 
Mix 7 
Mix 8 
Mix 9 
Mix 10 
Mix 11 
Mix 12 
Mix 13 
Mixl3R 
MixAl 
MixA2 
Mix A3 
Mix A4 
Mc; 
Mean 
mg/g 
20.8 
16.6 
12.8 
14.0 
17.7 
10.7 
18.6 
21.3 
23.4 
13.3 
20.2 
16.5 
15.5 
16.4 
14.0 
15.0 
14.9 
15.7 
StDev 
% 
1.8 
2.2 
5.7 
2.4 
1.9 
2.4 
1.8 
1.0 
2.2 
2.6 
2.7 
3.4 
3.8 
2.1 
3.2 
4.1 
3.5 
0.8 
C 
Mean 
mg g 
175.6 
230.2 
152.8 
154.8 
200.6 
246.8 
193.0 
243.4 
213.6 
169.3 
225.8 
136.7 
186.0 
193.9 
170.6 
195.3 
178.7 
180.8 
A 
StDev 
% 
1.7 
0.8 
4.3 
0.9 
0.5 
0.9 
1.1 
0.3 
1.5 
1.6 
1.1 
1.9 
1.8 
1.5 
2.7 
2.2 
2.1 
0.8 
Mean 
mg/g 
0.45 
0.48 
0.44 
0.68 
0.51 
0.69 
0.76 
0.78 
0.70 
0.87 
0.62 
0.59 
0.57 
0.58 
0.53 
0.54 
0.57 
0.52 
V13 
StDev 
% 
3.7 
3.3 
8.6 
2.4 
1.6 
2.3 
1.3 
4.6 
3.2 
4.1 
1.9 
2.2 
2.7 
1.3 
3.9 
2.0 
2.9 
2.4 
MS 
Mean 
mg/g 
0.230 
0.277 
0.361 
0.469 
0.186 
0.145 
0.427 
0.152 
0.370 
0.272 
0.377 
0.582 
0.347 
0.360 
0.373 
0.352 
0.424 
0.301 
StDev 
% 
3.9 
2.4 
11.8 
3.7 
6.4 
4.3 
3.2 
2.9 
4.4 
2.1 
1.4 
3.4 
5.0 
3.1 
5.8 
2.4 
3.8 
2.5 
"'A goodmodelcan advance fashion By ten years.''1 
Yves Saint-Laurent (b. 1936), quoted in "lliiz," no. 85 (London), 1.984 
CHAPTER 5 MODEL ELABORATION 
In the selected product, several components were targeted for on-line monitoring. For each of 
the components, an individual predictive multivariate model was elaborated. The elaboration 
of each of those models is described in the present section. 
From those models, two will be selected for the design of experiments test described in 
Chapter 2. 
5.1. Matrix preparation for preliminary models 
5.1.1. Calibration matrix 
A calibration matrix contains all data necessary to elaborate a multivariate model, hence both 
x- and y-variables for a predictive one. A single calibration matrix can be prepared for later 
elaboration of several models, as only the y-variable chosen will be changed for each model. 
In this case, the calibration matrix was prepared in such manner as to include all spectra 
collected for mixes 1 to 13, and one commercial batch. The total number of spectra was 
reduced by averaging the lines of the matrix by a factor of 10. This allowed obtaining one 
spectra that could be matched with each of the results obtained from the reference 
measurement. 
The reference values were entered manually for each sample. This operation left missing 
values for certain sample/component combinations, as it was impossible to obtain all reference 
measurements for one given sample. The missing values were filled with the average 
measurement of the component for the samples tested in the group (mix). For example, 
samples 1 to 3 of mix 1 were used to obtain ICP measurements for Calcium, Magnesium and 
Mineral 3, while samples 6 to 9 were used to obtain ICP and HPLC measurements for Mineral 
4 and Vitamin. The average measurement of samples 6 to 9 were used to fill missing values of 
samples 1 to 5 and 10, and the average measurement of samples 1 to 3 were used for samples 
4 to 10. 
The overall result was a 140 x 3 375 matrix. The columns included 5 y-variables and 3 370 x-
variables. 
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5.2. Elaboration of preliminary models 
5.2.1. Calcium 
Several pre-treatments were tested in order to obtain the best PLSR possible. Root Mean 
Square Error of Cross Validation (RMSECV), for a systematic 5 samples segmented cross-
validation, was used as the performance indicator for the choice of pre-treatments. The 
minimization of this value was considered the signal for optimal pre-treatment. Details 
regarding different calculated models are available in Table 5.1. 
Table 5.1: RMSECV of different Calcium predictive models 
PRK-TRFVTMFNT 
no pre-treatment 
Standard Normal Variate (SNV) 
Baseline Correction (Xr=1059.6 and X2=1183.7 cm"1) 
and normalization (X=989.9 cm"1) 
Baseline Correction (X!=1059.6 and X2=l 183.7 cm"1), 
normalization (X=989.9 cm"1) and 
exclusion of X-variables (951.6 to 1067.1 cm"1) 
RMSECV 
mg/g 
6.31 
8.53 
7.97 
8.19 
Chapter 51 Model elaboration 
The combination of linear baseline correction and normalization, with the X-variables basis 
mentioned in Table 5.1, was determined to be the best suited pre-treatment for the predictive 
model. Even though the use of raw spectra appears to lead to lesser RMSECV values, the 
absence of any pre-treatment leads to a higher prediction error and most likely lessens the 
models robustness in time and changing environmental conditions. 
Examination of appropriate plots did not lead to the finding of any outliers in the data set. The 
score plot (PC2 vs PCI) displayed in Figure 5.1 is a good example of outlier diagnostic plots. 
In this plot, each point represents the projection of one sample spectra in a 2D PC-space, and 
the coloration is concentration-correlated, from blue to red. All samples but those from mixes 
6 and 8 are well grouped and separated. Mix 6 and 8 have similar Calcium concentration and 
their entwinement is to be expected. This score plot tends to indicate that the first PC is 
strongly correlated to Calcium concentration. 
Figure 5.1: Score plot of Calcium PLSR - PC2 vs PCI 
£J>1 
The regression plot (refer to Figure 
5.3) illustrates the fit between the 
predicted and the measured Y-
variable values during the cross-
validation calculations. For the 
Calcium PLSR, the correlation at 
the calibration stage (R
 c) and at 
the validation stage (R
 v) were 
respectively 0.96 and 0.95, which 
indicates that good validation 
results can be expected. 
Both calibration and validation 
bias values calculated are close to 
null. The use of the previously 
described PLSR to predict the 
values of the samples in the 
validation matrix leads to 
satisfying results, as detailed in 
absolute values in Table 5.2. The 
mean error for commercial 
samples is less than 3 %. 
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Figure 5.2: Residual Validation Variance plot of 
Calcium PLSR 
Slope Offset RMSE R Square 
0 960268 7.584144 6.965870 0.960268 
0.949608 9.814693 7.966253 G S51681 
Catciuml - mix2.... (Y-var. PC): (Ca.2) (Qa.2) 
Figure 5.3: Regression plot of Calcium PLSR 
The overall calibrated range for the Calcium model is as expected, 75 to 135 claim%. 
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Table 5.2: Prediction error of different Calcium predictive models 
SAMPLES 
MixAl 
MixA2 
Mix A3 
Mix A4 
Commercial 
DIFFERENCE 
% 
4.92 
1.19 
1.52 
1.61 
2.83 
5.2.2. Magnesium 
First trials in data exploration 
revealed incongruities. The residual 
Validation Variance plot, illustrated 
in Figure 5.4, shows a sharp 
increase at the 4 PC. This fact, 
combined with an extraordinary 
poor prediction ability of 
preliminary PLSR attempts, lead to 
the conclusion that some samples or 
some variables were detrimental to 
the modeling. 
In order to identify the heavily and 
negatively leveraging items in the 
data set, the projection of the data 
in the first dimensions of the model 
was studied, in conjecture with its 
behavior in the regression plot. It is 
observed, as illustrated in Figure 
5.5 and Figure 5.6, samples from 
mix 1, 6 and 8 do not behave as 
could be expected. 
Residual Validation Variance 
A 
\ i 
\ i 
V 
I \ i K 
. \ 
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RESULT3D. Variabla: v.Total 
Figure 5.4: Residual Validation Variance plot for 
Magnesium data 
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Figure 5.5: Score plot of Magnesium exploratory 
analysis - PC2 vs PCI 
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Samples from mix 6 are poorly 
grouped on the regression plot and 
their predicted y-values do not fit 
with the measured ones. Samples 
from mix 1 and 8 appear out of the 
general direction of the regression 
on the regression plot, and they also 
appear in the "wrong" region of the 
score plot. 
Those observations tend to suggest 
that the regression could be 
improved by the removal of these 
data from the calibration dataset. 
Samples from mix 6 were removed, 
leading to a slightly cleaner 
correlation. A bump in the residual 
Validation Variance plot is still 
encountered after the second PC. 
Samples from mix 1 and 2 were 
away from the correlation's 
direction on the lower dimensions 
regression plots (Figure 5.8), while 
Slope Offset RMSE R-Square 
0.378938 10.25803 2.767686 0.378938 
0.245543 12.54866 3.301108 0.578376 
Mix! 
RESULT30. (Y-var. PCI: (Mq.3) tMq.3) 
Figure 5.6: Regression plot for Magnesium 
exploratory analysis 
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Figure 5.7: Score plot of Magnesium exploratory 
analysis - PC2 vs PCI 
samples from mix 1 and 8 were still incorrectly positioned on the score plot (Figure 5.7). An 
iterative-like process of removing a group of samples and checking the impact on the new 
PLSR resulted in the removal of samples from mix 1, 2, 6 and 9. 
After this optimization of the dataset, pre-treatments were investigated. Similar results as 
those presented for Calcium modeling allowed concluding that ideal pre-treatment was the 
baseline correction (Xi= 1059.6 and X2= 1183.7 cm"1) followed by a peak normalization 
(X = 989.9 cm"1). No further outliers were found in the data, as illustrated in Figure 5.9. 
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Figure 5.8: Regression plot for Magnesium exploratory analysis 
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Figure 5.9: Score plot of Magnesium PLSR- PC2 vs PCI 
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The use of 2 PC for this model 
allows explaining (73 + 15=) 
88 % of the X-variances and 
(72 + 21 =) 93 % of the Y-
variance. The Residual Validation 
Variance plot (Figure 5.10) 
indicates an important drop at 
PCI, leading to the conclusion that 
2 PC should be used for the 
Magnesium PLSR. 
The regression plot (Figure 5.11) 
illustrates the fit between the 
predicted and the measured Y-
variable values during the cross-
validation calculations. For the 
Magnesium PLSR, an R2C of 0.93 
and an R
 v of 0.92 indicates that 
good validation results can be 
expected. Both calibration and 
validation bias values calculated 
are close to null. 
The use of the previously 
described PLSR to predict the 
values of the samples in the 
validation matrix leads to 
satisfying results, as detailed in 
absolute values in Table 5.3. The 
mean error for commercial 
samples is less than 3 %. 
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Figure 5.10: Residual Validation Variance plot of 
Magnesium PLSR 
Slope Offset RMSE R-Square 
0.932047 1.092061 0 752002 0.932047 
0.913359 1.328821 0.829500 0 921840 
Maanesium18b. (Y-var. PC): (Mq.2) (M«.2S 
Figure 5.11: Regression plot of Magnesium PLSR 
Table 5.3: Prediction error of different Magnesium 
predictive models 
SAMPLES 
MixAl 
MixA2 
Mix A3 
Mix A4 
Commercial 
DIFFERENCE 
% 
8.24 
11.54 
9.54 
4.51 
2.72 
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Unfortunately, the overall calibration span of PLSR had to be sacrificed. It no longer covers 
the intended 70 to 150 claim%, but rather 79 to 143 claim%. 
5.2.3. Mineral 3 
The data exploration step revealed a very weak correlation between the y-variable and the x-
variables at the validation stage. The component being present at approximately only half of a 
percent in the mix, this weak correlation was to be expected. 
A PLSR of the raw data 
reveals that while the 
measured vs predicted y-
values are nearly perfectly 
correlated in the calibration 
stage (R2 = 0.99), the 
correlation is weak at best in 
the cross-validation stage 
(R2 = 0.53), as illustrated in 
Figure 5.12. 
A comparison of the peaks of 
the pure raw material to that F i S u r e 5 1 2 : M i n e r a l 3 r e g r e s s i o n P l o t > 1 3 p c 
of the overall commercial product revealed no isolated influential ones,meaning that no peak 
modifications could be directly attributed to the sole change in Mineral 3 concentration, thus 
explaining the weak correlation. 
The overall study suggested that no reliable PLSR could be obtained for the Mineral 3 
component. PLSR algorithm can be used to enhance an existing correlation between x- and y-
variables, but cannot provide one. A correlation must exist for the regression, whether PCR or 
PLSR, to be functional; and it appears in the present case that no such correlation exists in the 
data. 
Examination of the source material of Mineral 3 confirms that no Raman shifts should be 
expected, given that the bonds are mostly strongly polar. 
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5.2.4. Mineral 4 
First trials in data exploration 
revealed incongruities similar to 
those encountered in the 
Magnesium case. The residual 
Validation Variance plot, illustrated 
in Figure 5.13, shows a sharp 
increase in the lower PC, before the 
usual drop with the addition of 
more PC. 
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A process similar to that adopted in Figure 5.13: Residual Validation Variance plot for 
the case of the Magnesium data was Mineral 4 data 
followed in order to optimize the calibration set. 
The study of Score- and Regression-plots of the lower PC revealed that samples from mix 6, 7 
and 12 did not behave accordingly to the other groups. Examining the prediction ability of 
several PLSR elaborated with different combination of data confirmed that removing the three 
above-mentioned groups of data resulted in a sharp decrease of prediction error for the 
validation matrix. 
After the optimization of the dataset, pre-treatments were investigated. Similar results as those 
presented for Calcium and Magnesium modeling allowed concluding that ideal pre-treatment 
was the baseline correction (Xi= 1059.6 and X2= 1183.7 cm"1) followed by a peak 
normalization (X = 989.9 cm"1). 
No further outliers were found in the data, as illustrated in Figure 5.14. 
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Figure 5.14: Score plot of Mineral 4 PLSR - PC2 vs PCI 
The use of 10 PC for this model allows 
explaining almost 100 % of the X- and 
Y-variances variance. The Residual 
Validation Variance plot (Figure 5.15) 
still features a bump in the lower PC 
and indicates an important drop at 
PC6, leading to the conclusion that 
7 PC should be used for the Mineral 4 
PLSR. However, The Unscrambler® 
Residua/ Validation Variance 
\ 
• \ 
: \ 
\ \ ! 
\ : 
K 
;
 .. .. !. \ 
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Zinc 12. Variable: v Total 
software suggests using 10 PC, based Figure 5.15: Residual Validation Variance plot of 
, * , . . , , . * Mineral 4 PLSR 
on the tact that a significant amount ot 
variance is explained by the addition of 3 more PC. Studying the prediction error of models 
including 6 to 11 PC revealed that the optimum is at 10 PC, with the 11 bringing no 
significant improvement. 
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The regression plot (Figure 5.16) 
illustrates the fit between the predicted 
and the measured y-variable values 
during the cross-validation 
calculations. For the Magnesium 
PLSR, an R2C of 0.99 and an R2V of 
0.89 indicates that good validation 
results can be expected. Both 
calibration and validation bias values 
calculated are close to null. 
The use of the previously described 
PLSR to predict the values of the 
samples in the validation matrix leads 
to satisfying results, as detailed in 
Table 5.5. The mean error for 
commercial samples is less than 7 %. 
Unfortunately, the overall calibration 
span of PLSR also had to be sacrificed. 
It no longer covers the intended 70 to 150 claim%, but rather 78 to 150 claim%. 
5.2.5. Vitamin 
The data exploration step revealed a very weak correlation between the y-variable and the x-
variables at the validation stage. The Vitamin being present at less than a quarter of a percent 
in the mix, this weak correlation was to be expected. 
Moreover, this Vitamin is only composed of Carbon, Hydrogen and Oxygen, which makes it 
indistinctable from several other raw materials in the overal formula. 
A PLSR of the raw data reveals that while the measured vs predicted y-values are neatly 
correlated in the calibration stage (R = 0.93), the correlation is weak at best in the cross-
validation stage (R2 = 0.52), as illustrated in Figure 5.17. 
Stop© Offset RMSE R-Square 
0.990052 0.023758 0.050295 0.990052 
0.86609S 0 328937 0.175742 0.SE5159 
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Figure 5.16: Regression plot of Mineral 4 PLSR 
Table 5.4: Prediction error of different Mineral 4 
predictive models 
SAMPLES 
MixAl 
MixA2 
Mix A3 
Mix A4 
Commercial 
DIFFERENCE 
% 
6.08 
10.77 
14.72 
4.58 
5.19 
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Figure 5.17: Vitamin regression plot, 13 PC 
A similar approach to that explained for Magnesium and Mineral 4 was followed in order to 
try and tweak the correlation, but improved correlation at the validation stage did not allow 
reducing the error to an optimistic level. 
5.3. Models for the main design study 
In light of the previous results, Calcium and Magnesium data were chosen for the execution of 
the design of experiment. The design will be executed and analyzed separately for each of the 
components, allowing independent conclusions to be drawn. 
5.3.1. Calibration matrix preparation 
As described in Chapter 2, 16 models were to be made with different data combination for 
each mineral. Table 2.2 is repeated here for clarity. 
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Table 2.2: I iv 1/8 fractional factorial design (repeated) 
RlN 
# 
3 
11 
7 
15 
1 
9 
5 
13 
4 
12 
8 
16 
2 
10 
6 
14 
A 
auto. 
auto. 
auto. 
auto. 
auto. 
auto. 
auto. 
auto. 
manual 
manual 
manual 
manual 
manual 
manual 
manual 
manual 
B 
cone. 
cone. 
cone. 
cone. 
even 
even 
even 
even 
cone. 
cone. 
cone. 
cone. 
even 
even 
even 
even 
C 
6(5)* 
6(5) 
13(9) 
13(9) 
6(5) 
6(5) 
13(9) 
13(9) 
6(5) 
6(5) 
13(9) 
13(9) 
6(5) 
6(5) 
13(9) 
13(9) 
FACTORS 
1) 
PCR 
PLS 
PCR 
PLS 
PCR 
PLS 
PCR 
PLS 
PCR 
PLS 
PCR 
PLS 
PCR 
PLS 
PCR 
PLS 
K F <; 
absent 10 ref. 
absent 5 exp. 
present 5 exp. 
present 10 ref. 
present 5 ref. 
present 10 exp. 
absent 10 exp. 
absent 5 ref. 
present 10 exp. 
present 5 ref. 
absent 5 ref. 
absent 10 exp. 
absent 5 exp. 
absent 10 ref. 
present 10 ref. 
present 5 exp. 
^Number in parenthesis denotes factor associated with 
Four (4) of the specified combinations require that 
Details concerning the combination and the samples 
illustrated in Figure 5.18 and Figure 5.19. 
Magnesium models 
different calibration samples be used, 
selected are available in Table 5.5 and 
Tab e 5.5: Calibratio n sample select ion for design oi experiment requirem 
DOE RUNS 
CONCERNED 
3,4 ,11,12 
1,2,9,10 
7,8,15,16 
5,6,13,14 
COMBINATION 
B: cone. 
C: 6 (5)+ 
B:even 
C: 6 (5) 
B: cone. 
C: 13 (9) 
B:even 
C: 13 (9) 
Mix SKLKCTKD 
(Ca) 
6, 9,12,13, Al, 
A4 
2,6,9,10,12,13 
1,2,4,6,7,9,10, 
12,13,A1,A2, 
A3,A4 
l t o l 3 
MlXSKLF.CTF.D 
(Mg) 
3, 8,13, Al, A3 
3,5,8,11,13 
3, 7, 8,12,13, Al, 
A2, A3, A4 
3,4 ,5 ,7 ,8 ,10,11, 
12,13 
Numbers in parenthesis denote the combination for Magnesium models 
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Figure 5.19: Calibration point distribution according to DoE - Magnesium 
5.3.2. Characteristics of elaborated models 
Multivariate predictive models were elaborated according to pre-treatments described 
previously and data selection corresponding to each run in DoE. Characteristic values for each 
models are detailed in Table 5.6. 
p.__63 
Table 5.6: Characteristics of models developed for each run 
Rl'N 
# 
1 
-> 
3 
4 
5 
6 
1 
8 
9 
10 
n 
12 
13 
14 
15 
16 
PC 
1 
5 
1 
2 
-» 
6 
T 
"> 
1 
3 
*» 
1 
-> 
3 
-> 
4 
CALCIUM 
CALIBRATION 
RMSK 
mg/g 
(>.5 
5.8 
—, ~\ 
8.8 
6.9 
7.9 
7.0 
1 1 . 9 
~.8 
7.9 
5.3 
8.7 
6.1 
6.8 
6." 
7.9 
R2 
0.96 
0.97 
0.9" 
0.94 
0.95 
0.92 
0.96 
0.89 
0.9S 
0.95 
(I.9S 
0.95 
0.95 
0.94 
().9h 
0.95 
VALIDATION 
RMSK 
mg-g 
".() 
7.3 
7.S 
9.3 
7.1 
8.4 
7.4 
12.6 
8.1 
9.0 
6.0 
9.3 
6.6 
7.7 
(>.9 
8.5 
R2 
0.9ft 
0.96 
0.96 
0.94 
0.95 
0.92 
0.96 
0.88 
0.95 
0.93 
0.9S 
0.95 
0.95 
0.93 
0.96 
0.94 
MAGNESllVl 
PC 
2 
2 
1 
5 
6 
7 
5 
9 
2 
3 
1 
3 
5 
7 
5 
4 
CALIBRATION 
RMSK 
m&g 
0.33 
0.5 
0.4 
0.7 
0.7 
0.8 
0.5 
0.5 
0.4 
0.4 
0.5 
0.7 
0.6 
0.4 
0.4 
0.7 
R2 
0.99 
0.98 
0.98 
0.95 
0.93 
0.90 
0.97 
0.97 
0.99 
0.98 
0.98 
0.96 
0.96 
0.97 
0.98 
0.94 
VALIDATION 
RMSF. 
mg/g 
0.36 
0.5 
0.5 
0.8 
0.8 
0.9 
0.6 
0.7 
0.4 
0.5 
0.6 
0.8 
0.8 
0.7 
0.5 
0.7 
R2 
0.99 
0.97 
0.98 
0.94 
0.91 
0.88 
0.97 
0.95 
0.99 
0.98 
0.97 
0.94 
0.92 
0.91 
0.97 
0.93 
5.4. Models for the batch-volume-effect study 
The preliminary models described in Section 5.2 for Calcium and Magnesium were used to 
obtain predicted values of mineral concentration for each level of batch volume. 
"jl// truths are easy to understand once they are discovered; t/ie point is to 
discover them" 
Galileo Galilei (1564-1642), unsourced 
CHAPTER 6 ANALYSIS OF EFFECTS 
In the present Chapter are detailed the analysis that were conducted in order to obtain and 
interpret the results of the design of experiment presented in Chapter 2. 
6.1. Main design 
6.1.1. Response to analyze 
Models presented in the previous Chapter were used to predict the content in Calcium and 
Magnesium of new spectra obtained from commercial samples. 
Fifty (50) tablets of a commercial batch were scanned, using the same parameters as for the 
development samples. Spectra were averaged so 10 spectra obtained from 5 tablets are 
displayed as one. Hence, the 50 tablets resulted in 100 spectra that were averaged into 10 final 
spectra. Those raw spectra were then arranged in a validation matrix, for later use with all 
elaborated MVPM. 
All 32 models elaborated for the execution of the design of experiment for two different 
ingredients were used to obtain the content prediction associated with the collected spectra. 
Actual ("true") content of the validation spectra was assumed to be the commercial claim of 
each ingredient. Because this product has been manufactured for a long period of time and the 
controls of the manufacturing and quality testing are very strict, this assumption should not 
introduce any significant error. 
Summarized results for the prediction of Calcium and Magnesium content for each DoE runs 
are presented in Table 6.1 as absolute value of the relative difference between the prediction 
and theoretical value. For information purposes, the same error was calculated for results 
obtained with the qualified ICP method for the same commercial batch. They are tabulated in 
the last line (identified as "ICP" in column 1). 
All following analysis are based on these summarized results. 
p. 64 
R- 65 
6.1.2. Method of analysis 
The design of experiment gives data that is already Table 6.1: Prediction results for 
arranged to be studied with an ANOVA. The measured 
RUN 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
ICP 
DIFFERENCE 
C A M C 
% % 
7.34 7.82 
6.85 1.64 
4.23 6.92 
2.34 9.24 
4.13 55.93 
1.28 30.24 
3.75 45.78 
4.85 38.22 
8.27 6.09 
7.98 11.44 
2.55 6.36 
9.13 1.78 
1.63 79.23 
1.14 60.52 
1.79 46.99 
3.19 21.45 
0.19 1.02 
response is simply added to the data that constitute the 
design parameters and all desired studies can be started 
from the database thus created. 
In the present case, the average of the absolute values 
of the relative difference between the prediction and the 
theoretical values was used as the response to be 
analyzed (refer to Eq. 3). Hence, the effect of each 
parameter variation on this difference is studied. In 
order to avoid underestimating the error component of 
the ANOVA, the response had to be averaged. The 10 
concentration predictions are indeed not true replicates. 
They must be considered as duplicates and therefore 
the ANOVA procedure must be conducted with great 
care in order to correctly identify the components that will be pooled into the experiment error, 
on which all significance testing will be later based. 
To facilitate error calculation and pooling, the factor E (prod.) was used as a blocking variable, 
since first ANOVA attempts suggested its influence was marginal. The blocking variable is 
included in all ANOVA just like any other factor, so it doesn't change the intent of the DoE. 
Stat Soft Inc.'s Statistica software was used to do 2 individual ANOVA, one for each selected 
mineral. The ANOVA were first based on a model that included all 2-way interactions. 
Normal and half-normal probability plots of effects were examined in order to determine 
which effect (and their confusions) was to be pooled into the error. Once the error had been 
correctly pooled, the ANOVA were redone with the remaining factors and interactions. Error 
terms were calculated based on Sum of Square residual. The analysis of residuals and data 
transformation, when applicable, are described in Annex 4, and allowed to check that all 
hypotheses on which an ANOVA relies were met. 
Chapter 6. Analysis of effects 
6.1.3. Error component determination 
For the Calcium ANOVA, a model including all 3-way interactions was used to obtain the 
first half-normal p-plot. In order to allow an invertible matrix, the following interactions were 
also automatically pooled into the error component: 2x5 and all further 2-way interactions, 
1x2x3, 1x2x5 and all further 3-way interactions. This led to the modeling of only 2-way 
interactions based on the first factor (lx...), plus the 2x3 and 2x4 as well as the 1x2x4. 
Normal and half-normal p-plots were obtained after this model-tweaking and are available in 
Figure 6.1. They indicate that interactions 1x3, 2x4 and 1x2x4 and their aliases can be pooled 
into error because their position in the plots suggests that they are not significant. Along with 
those interactions, others were automatically pooled to allow an invertible matrix in which 
only interactions 1x2, 1x4, 1x5,1x6 and 2x3 could be estimated. 
Probability Plot; Var.:Ca-dSff_moy; R-sqr=1. 
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Figure 6.1: Half-normal probability plot for error pooling - Calcium 
For the Magnesium ANOVA, the same approach was used. The same interactions as for the 
Calcium analysis were also automatically pooled into the first error component in order to 
allow an invertible matrix. The half-normal p-plot obtained is available in Figure 6.2. 
Observation of this plot led to the conclusion that interactions 1x4, 1x5 and 1x2 could be 
pooled into the error component, along with their aliases, because their position in the plots 
E,67 
Probability Plot; Var.:Mg_diff_moy; R-sqr=1. 
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Figure 6.2: Half-normal probability plot for error pooling - Magnesium 
6.1.4. ANOVA results 
All abbreviations and denotations in this section are used according to design presented in 
Table 2.1 and Table 2.2. For more clarity, confusions are not detailed in the charts and tables 
but are available in Table 2.3. Results of ANOVA are detailed in Table 6.2 and Table 6.3. 
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Table 6.2: ANOVA results for Calcium data 
FACTOR SS DF MS F-VALUE P-VALUE 
Block (E, Prod) 
(A) Press 
(B)Distrib 
(C)NbPts 
(D)Algo 
(F)Replic 
(G)Meas 
AB 
AD 
AF 
AG 
BC 
0.009 
0.589 
2.882 
45.327 
0.052 
1.015056 
2.258 
7.995 
8.023 
6.669 
11.273 
19.338 
I 0.009 
0.589 
I 2.882 
I 45.327 
I 0.052 
I 1.015 
t 2.258 
I 7.995 
I 8.023 
I 6.669 
I 11.273 
I 19.338 
0.006 
0.432 
2.114 
33.261 
0.038 
0.745 
1.657 
5.867 
5.887 
4.894 
8.272 
14.191 
0.941833 
0.557824 
0.241887 
0.010362 
0.857936 
0.451584 
0.288379 
0.093990 
0.093630 
0.113863 
0.063730 
0.032732 
Error 4.088 3 1.363 
Total 109.516 15 
Table 6.3: ANOVA results for Magnesium data 
FACTOR 
Block (E, Prod) 
(A) Press 
(B)Distrib 
(C)NbPts 
(D)Algo 
(F)Replic 
(G)Meas 
AC 
AG 
BC 
BD 
Error 
Total 
SS 
10.128 
405.922 
362.617 
6685.924 
90.583 
175.89391 
15.269 
346.053 
90.108 
313.202 
454.010 
128.958 
9078.666 
DF 
4 
15 
MS 
10.128 
405.922 
362.617 
6685.924 
90.583 
175.894 
15.269 
346.053 
90.108 
313.202 
454.010 
32.239 
F-VALUE 
0.314 
12.591 
11.248 
207.383 
2.810 
5.456 
0.474 
10.734 
2.795 
9.715 
14.082 
P-VALUE 
0.605047 
0.023834 
0.028470 
0.000135 
0.169004 
0.079746 
0.529169 
0.030608 
0.169880 
0.035634 
0.019901 
Results of ANOVAs are also summarized in a modified Pareto chart, illustrated in Figure 6.3. 
In this figure, a bar that continues past the p = 0.05 limit indicates that the associated factor, in 
the associated ANOVA, was found to have a significant effect on the response. For example, 
factor B (Distrib.) is indicated to have a significant effect in the case of the ANOVA on 
Magnesium data, but not on Calcium data. Numbers provided at the end of each bar are the t-
values (df = 3 for Calcium and 4 for Magnesium). 
p. 69 
Figure 6.3: Modified Pareto chart of ANOVA - main effects 
Observation of the results suggests that they can be categorized as follows. Conclusions 
regarding the significance of a factor can be: 
1) the same, regardless of core data used for the ANOVA: 
a. significance and importance of the factor are the same; 
b. significance of the factor is the same but not importance; 
2) different depending on the data used for the ANOVA; 
a. significance and importance are not the same; 
b. significance is not the same but importance is the same. 
Results were classified according to the type of conclusion described previously and are 
presented in Figure 6.4. Significance is based on the p-value and is compared to the p = 0.05 
limit. Importance is, in this case, a subjective quality that denotes the "weigh" the factor 
would have in an eventual optimisation or prediction DoE model. Importance was determined 
to be the same if the two t-values were less than 50 % different. Interactions were excluded 
from this analysis since the estimable ones were not the same in each ANOVA. 
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Figure 6.4: Difference in ANOVA conclusions - Calcium vs Magnesium 
6.1.5. Design projection 
As suggested in Chapter 2, a collapse of the design can be done. This is a procedure by which 
the original 2k~p fractional design is projected into a 2 full factorial design. The selection of 
factor subsets to project in the full factorial design is taken from the subsets that are not part of 
the original design's defining relation. In the case of the 27"3 design, those unusable subsets are 
ABCE, BCDF, ADEF, ACDG, BDEG, ABFG and CEFG. All 28 remaining subsets of 4 
factors could be use for the projection. 
In this particular case, it is wished to retain the factors that were previously deemed significant, 
either for the Calcium or the Magnesium data, which are A, B and C. The fourth factor chosen 
will be D, because the interaction BD was found to be significant in the case of Magnesium 
data. The subset ABCD is not part of the defining relation of the original data and can 
therefore be projected into a full 2 design. 
This projection was analyzed the same way as previous ones. The half-normal p-plots that 
were obtained when including all main effects and interactions are available in Figure 6.5 and 
Figure 6.6, for Calcium and Magnesium data, respectively. 
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Figure 6.5: Half-normal p-plot of effects - projected Calcium data 
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Figure 6.6: Half-normal p-plot of effects - projected Magnesium data 
Chapter 6. Analysis of effects 
The examination of those plots led to the conclusion that interactions 1x2x3, 2x4, 2x3x4 and 
1x3 should be pooled in the error component for Calcium data and interactions 1x4, 1x2, 
1x2x3 and 1x3x4, for Magnesium data. 
Results of the ANOVA conducted following this model-tweaking are detailed in Table 6.4 
and Table 6.5. 
Table 6.4: ANOVA results for Calcium data 
FACTOR 
(l)Press 
(2)Distrib 
(3)NbPts 
(4)Algo 
l b y 2 
l b y 4 
2 by 3 
3by4 
1*2*4 
1*3*4 
Error 
Total SS 
SS 
0.5891 
2.8815 
45.3266 
0.0518 
7.9948 
8.0231 
19.3380 
11.2728 
2.4103 
2.2575 
9.3709 
109.5161 
DF 
5 
15 
MS 
0.58906 
2.88151 
45.32656 
0.05176 
7.99476 
8.02306 
19.33801 
11.27281 
2.41026 
2.25751 
1.87418 
F-VALUE 
0.31430 
1.53748 
24.18479 
0.02762 
4.26574 
4.28084 
10.31814 
6.01481 
1.28603 
1,20453 
P-VALlj!E;:f 
0.599243 
0.270010 
0.004406 
0.874527 
0.093791 
0.093356 
0.023671 
0.057758 
0.308206 
0.322438 
Table 6.5: ANOVA results for Magnesium data 
FACTOR 
(l)Press 
(2)Distrib 
(3)NbPts 
(4)Algo 
l b y 3 
2 by 3 
2 by 4 
3 by 4 
Error 
Total SS 
SS 
405.922 
362.617 
6685.924 
90.583 
346.053 
313.202 
454.010 
90.108 
330.249 
9078.666 
DF 
1 
1 
1 
1 
1 
1 
1 
1 
7 
15 
MS 
405.922 
362.617 
6685.924 
90.583 
346.053 
313.202 
454.010 
90.108 
47.178 
F-VALUE 
8.6040 
7.6861 
141.7158 
1.9200 
7.3350 
6.6387 
9.6233 
1.9099 
P-VALUE 
0.021923 
0.027599 
0.000007 
0.208396 
0.030273 
0.036656 
0.017270 
0.209462 
Those results lead to the same conclusions than with the fractional design. This suggests that 
error pooling was done adequately in the fractional design. Number of degrees of freedom for 
error calculation is also increased above the recommended limit of 5. This is an indication that 
error pooling is done adequately in this ANOVA and results are reliably obtained. 
£ ,73 
concentration was taken to be the 
theoretical one, as no other 
measurements were done on those extra 
samples. 
Full results for the prediction of 
Calcium and Magnesium content for 
each batch-volume size are presented in 
Table 6.6 as the absolute value of the 
relative difference between the 
prediction and the theoretical value. All 
following results and analysis are based 
on this data. 
6.2.2. Method of analysis 
A one-way break-down ANOVA was done i 
values of the relative difference between the pi 
BATCH T A B L E T / 
VOLUME B A T C H RATIO 
g % 
1 100 
6 16.67 
16 6.25 
3200 0.03 
RULATI\ E DIFFERENCE 
CALCIUM MAGNESIUM 
% % 
5.21 5.46 
1.44 0.36 
11.55 13.30 
3.54 11.54 
2.18 11.61 
8.07 7.48 
14.84 4.73 
13.05 15.60 
1.77 6.00 
7.84 3.63 
3.11 5.43 
6.97 3.99 
order to interpret those results. The absolute 
diction and the theoretical values were used as 
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response to be analyzed (refer to Eq. 3). Hence, the effect of batch size variation on this 
difference is studied. 
All 3 duplicates were used in this analysis. This could lead to an underestimation of the error 
component on which the significance testing is based. This means that the factor will be 
judged significant "more easily". 
Stat Soft. Inc.'s Statistica software was used to do 2 individual ANOVA, one for each selected 
mineral. The analysis of residuals are described in Annex 4, and allowed to check that all 
hypotheses on which an ANOVA relies were respected. 
6.2.3. Results 
Results of ANOVA are detailed in Table 6.7 and Table 6.8. They indicate that the batch size 
does not influence the prediction error of both the Magnesium and the Calcium models. Given 
this result, the error underestimation due to the use of duplicates as replicates is not of 
consequence and no further testing needs to be done. 
Table 6.7: ANOVA results for Calcium data 
EFFECT 
intercept 
batch size 
Error 
SS 
527.5 
46.4 
184.3 
DF 
1 
3 
8 
MS 
527.5 
15.5 
23.0 
F-VALUE 
22.90 
0.67 
P-VALUE 
0.001 
0.593 
Table 6.8: ANOVA results for transformed Magnesium data 
FACTOR SS DF MS F-VALUE P-VALUE 
intercept 662.0 1 662.0 314 0.0005 
batch size 60.5 3 20.2 0.96 0.4587 
Error 168.6 8 21.1 
"'Everything should be made as simple as possible, but not simpler:"' 
Albert Einstein (1879-1955)/ quoted in On the Method of 
Theoretical Physics, 1934 
CHAPTER 7 RESULT INTERPRETATION 
7.1. Interpretations for factors with no effects 
The following factors do not have 
any significant effect on the 
response, no matter if it is tested on 
the Calcium or the Magnesium data 
set: factors D (calibration algorithm 
used), E (use of commercial 
samples in the calibration set), F 
(number of replicates used per 
calibration point) and G (type of
 F i g u r e 7 . 1 : Effect of factor D on measured response 
reference measurement used in the 
calibration step). The plots of 
means for those four factors are 
available in Figure 7.1 to Figure 
7.4. 
The conclusion reached for factor D 
is in accordance with literature on 
the subject. It is indeed widely 
agreed that both algorithm can lead
 F i g u r e 72. E f f e c t o f f a c t o r E o n m e a s u r e d r e Sp0nSe 
to a good model, but that, in 
general, PLS will do it using fewer PC [Esbensen, 2004]. 
No literature was found on the use of commercial samples in the calibration stage of a 
MVPM-based PAT (factor E), but the results obtained are in accordance with the general 
calibration procedure. As it is the goal to produce samples that are as close as possible to the 
future ones (hence the commercial ones), it is not surprising to find that, when such goal is 
achieved, including the real commercial samples in the calibration set does not make much of 
a difference. In the case that obtaining life-like samples is more difficult, the inclusion of 
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Chapter 7. Result interpretation 
commercial samples in the calibration set might be of a certain help when fine-tuning the 
model, but this remains to be tested. In the present case, the most convenient approach should 
prevail. 
I 
17 
10 
Factor F level ~»-Magnesium 
-•—Calcium 
Figure 7.3: Effect of factor F on measured response 
The conclusion reached in the case 
of factor F is a positive surprise. It 
was expected, in accordance with 
the general calibration procedure, 
that including more samples, and 
thus more variation, in the 
calibration matrix, would allow the 
model to better perform in the 
validation stage and in future use. It 
appears that, no matter how many 
replicates are included in each 
calibration point, the response is not 
affected. It was expected that a 
decreasing asymptote-like response-
plot would be obtained when 
increasing the number of replicates, 
thus suggesting an optimal number 
of replicates at the lowest error 
obtained with the least number of Figure 7.4: Effect of factor G on measured response 
samples; this was not the case. 
The results obtained can be explained in regard with the particular application of validating 
with commercial samples. Because they are manufactured in such a manner that they are very 
uniform from batch to batch, the inclusion of more variation in the calibration stage may not 
be as crucial as in other cases where more variation will be encountered in the application of 
the model. On the other hand, including more replicates in the calibration stage may increase 
model robustness over time. This was not investigated in the present study and should be kept 
in mind when optimizing the development protocol. More tests were made regarding Factor F 
Theo. Ref. 
Factor G level 
-Magnesium 
-Calcium 
2.J1 
When looking back at the development data presented in Table 4.2 and Table 4.3, the 
difference in standard deviation of sample reference measurements correlates with the 
previous suggestions. Standard deviation associated with Magnesium data are systematically 
higher than that of Calcium data, for a given manufacturing method (press used). Also, 
standard deviation associated with data measurements (both Calcium and Magnesium), are 
systematically higher in samples manufactured with the single-punch manual press than with 
the larger-scale automatic one. Those observations are hence in direct agreement with 
previous expectations. 
In light of the results obtained, the previous explanations must be revised and completed in 
order to explain the new results. First, it can be added that the reference measurements have 
an error (or precision) of their own. Including the reference measurements in the calibration 
stage consequently includes this error in the model. Theoretical values also have an error, but 
there is no a priori telling which error is "better", even though it was originally postulated that 
the reference one was better because it is the reference measurement that is to be replaced by 
the MVPM-based PAT. Training the model with this error was expected to give better result. 
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Another prejudice is linked with the increased difficulty when dealing with dry powder mixes. 
Linking theoretical concentration with a sample of a liquid mix is more easily done than with 
a powder mix, because of their respective behavior and proneness to segregation or local 
inhomogeneities, thus suggesting that a reference measurement would be better. On this 
subject, the mean difference between the theoretical and the reference values was checked for 
the samples manufactured with the automatic press, and is of 1.9 and 1.2 % for Calcium and 
Magnesium, respectively. This deviation is within the reference method's precision range, 
suggesting that the difference might not be statistically significant. At the light of this 
information, the conclusion reached regarding the effect of factor G is no longer surprising. 
Both concentration measurements are equivalent, which leads to equally well-calibrated 
models. The difference between reference and theoretical values are greater when dealing with 
samples manufactured using the manual press: respectively 3.9 and 2.3 %. Those results are in 
agreement with the fact that factor A (press used) has a significant effect on the response. 
Because manipulation errors are intrinsically various and mostly not repeatable, it is possible 
that, while in this case they are equivalent to that of the reference method, they might be 
greater or lesser in any other case. As such, it is suggested, as detailed in Chapter 11, that 
more studies be conducted regarding the effect of factor G. 
7.2. Interpretation for factors with effects 
7.2.1. Factor A, type of press used for sample manufacturing 
The significance of the effect of 
factor A on the measured response is 
not the same, depending if the test is 
run with the Calcium or the 
Magnesium model, as illustrated in 
Figure 7.5 and Figure 7.6. The main 
difference between those two models 
is that they are aimed at raw 
materials that are present in 10-fold 
Figure 7.5: Effect of factor A on measured 
concentration difference. response, Calcium data only 
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The manufacturing steps particularly involved in this phenomenon and their potential 
contribution to the effect are discussed in greater length in Section 7.3. 
Factor A is also part of significant interactions with factor C (number of calibration points 
used) in the case of Magnesium data. Means plot for Magnesium data must hence be 
presented in a manner that reflects this interaction. 
Means plot of response for factor A with magnesium data is presented in Figure 7.6, with 
respect to the level of factor C. It can be seen from this plot that when there is a low number 
of calibration points, factor A does not have a significant effect, while at high number of 
calibration points, using the 'manual' calibration set lowers the error. 
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Because factor C was part of a 
subsequent test, results of which are 
presented further along this 
document, no details regarding the 
interpretation of those results will be 
given here. For the moment, it may 
be said that because of the 
particularities associated with factor 
C, it is suspected at this point that the 
Figure 7.6: Effect of factor A on measured response 
press used is not the real source
 w i t h varying levels of factor C - Magnesium data 
of variation in this case, but rather the calibration points themselves. More details will be 
given in subsequent sections. 
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7.2.2. Factor B, distribution of calibration points 
The significance of the effect of 
factor B on the measured response is 
different, depending if the test is run 
with the Calcium or the Magnesium 
model, as illustrated in Figure 7.7 and 
Figure 7.8. Moreover, factor B shows 
a significant interaction with factor C, 
both for Calcium and Magnesium 
data, as well as with factor D for 
Magnesium data. 
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Figure 7.7: Effect of factor B on measured response 
with varying levels of factor C - Calcium data 
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The latter is shown in Figure 7.9. 
This can probably be explained with 
the same reasons as the problems 
encountered while elaborating the 
original models (refer to Section 5.2), 
as well as those sketched in Section 
7.2.1. Selecting samples only 
distributed closely around the target 
concentration may have removed an 
amount of healthy variation that 
helped with later predictions of 
commercial samples. More details 
will be discussed in the analysis of 
the subsequent tests regarding 
factor C. 
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Figure 7.8: Effect of factor B on measured response 
with varying levels of factor C - Magnesium data 
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Figure 7.9: Effect of factor B on measured response 
with varying levels of factor D - Magnesium data 
7.2.3. Factor C, number of calibration points 
The significance of the effect of 
factor C on the measured response is 
the same, no matter if the test is run 
with the Calcium or the Magnesium 
model, as illustrated in Figure 7.10, 
Figure 7.11 and Figure 7.12. The 
means plot detail effects of 
Significant 
interactions as well. factor 
Calcium 
Factor C level 
Bat-1 
-Bat+1 
Figure 7.10: Effect of factor C on measured response 
with varying levels of factor B - Calcium data 
Chapter 7. Result interpretation 
The effect of the factor on the 
response appears to be opposite 
between the two data set. Using 
more points is beneficial for 
Calcium data but detrimental for 
Magnesium data. This factor will be 
part of an additional study presented 
later in this document and its effect 
will be analyzed in greater details at 
this occasion. 
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Figure 7.11: Effect of factor C on measured 
response with varying levels of factor B — 
Magnesium data 
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Figure 7.12: Effect of factor C on measured response with varying levels of factor A -
Magnesium data 
7.3. Other factor studied ("series 2") 
As mentioned earlier and illustrated in the means plot presented in Figure 7.13, varying the 
batch volume when manufacturing calibration samples does not have an impact on the 
measured response, no matter if the test is run with the Calcium or the Magnesium model. 
£.83 
Figure 7.13: Effect of batch size on the measured response 
As described previously, it was found that the type of press used for sample manufacturing 
(factor A) did have an effect on the model's ability to produce accurate predictions, especially 
for the lower-concentration raw material. It was unclear, though, if the effect was caused by 
the use of a different press or by the specific selection of calibration point in the calibration 
matrix (as will be detailed in Chapter 8). 
But, even without specifically knowing if it is really factor A that has an influence, it is 
possible to try and see if, in the case that it does have an effect, it really is because of the press 
used. This is why the effect of batch volume was studied. The result obtained hence 
complements the previous one because it allows separating some manufacturing steps and 
better concluding on the exact origin of the disturbance discovered in the samples. 
As a reminder, the manufacturing process for development samples are detailed Table 7.1, 
along with the main challenges associated with manufactured batch size. 
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Table 7.1: Challenges in manufacturing of development samples 
M A M i'-tf ii M V ; 
S ll-.l-
Raw material 
weighing 
Mixing step(s) 
Tablet 
compression 
CllAl l | N f ; | S U | | | ' N \ \ C I K K I M . IN 
MK.IItN-VOI 1 Ml' II VM lll-.S 
• Scales that weigh in kilograms 
have lesser precision and this 
may lead in inexactitudes in the 
expected raw material content 
of final samples. 
• Filling and emptying of V-
blender with powdered samples 
may lead to a loss of either raw 
material (when filling) or end 
mixed-product (when 
emptying). The former loss can 
lead to inexactitudes in the 
expected raw material content 
of final samples. 
• Medium-scale presses used 
with small volume batches 
(such as 3200g) are more 
difficult to control and greater 
tablet-to-tablet hardness 
variations are to be expected. 
( l l -M 1 IV;i-s\MII-.N\VOI<klN<;iN 
i.tmi K-vni.i\ii B\K ins 
• It is more dillicuil lu uouuii Uie 
exact desired weigh when it is a 
fraction of a gram and the 
powder is not very fine; 
• Patience of the experimenter 
may wear off, leading to error or 
"sloppy" weighing; 
• Any small particle present on the 
scale after the tare will influence 
more greatly the end-result. 
• The mixing has to be done in a 
manner that is not representative 
of that done at a higher-scale (V-
blender), which can lead to 
greater risk of local 
inhomogeneities. 
• The action of letting a small 
quantity of powder slide on a 
plastic cup into the matrix, one 
by one, induces powder 
segregation, which can lead to 
intra-tablet inhomogeneities. 
As can be seen from the information presented, the fact that factor A was found to be 
significant is not solely attributable to the press used. It could be a combination of any steps 
implied in the manufacture of lower-volume batches. But because samples from different 
batch sizes were prepared and compressed with a small-scale tablet compression machine, and 
since no effect was registered when varying the scale of step 1 and 2, these first two 
manufacturing steps can be removed from the possible suspect in the explanation of factor A's 
significance. 
Hence, combining the results from factors "press used" and "batch volume" points to the 
conclusion that it is more likely that the segregation caused by the smaller-scale press is the 
phenomenon responsible for the effect of factor A on the accuracy of the MVPM, provided it 
really has an effect on the response. 
"'Design can Be art. (Design can he aesthetics. 'Design is so simple, that's 
why it is so complicated" 
Paul Rand (1914-1996), Variously sourced 
CHAPTER 8 ADDITIONAL DESIGN 
8.1. Design 2 - Factor C and F 
8.1.1. Context and design methodology 
In order to obtain more information on the effect of the available continuous factors (C and F), 
an additional design was prepared. This design will be made with more than two levels, so a 
response map can be obtained. 
Factors that were left out were fixed at their optimal value, corresponding to that minimizing 
the error, as illustrated in the graphs presented in Chapter 7. In making the calibration set, the 
samples manufactured with the automatic press (factor A and batch volume) will be used, 
without the commercial samples (factor E). The calibration points will be chosen in a manner 
that insures as much as possible an even distribution of the points along the calibration span 
(factor B) and the PLS algorithm will be used for modeling (factor D), with the Y-variable set 
as the reference measurement (factor G). 
The design was also prepared with StatSoft's Statistica software. A Central composite design 
with 2 factors was used to generate the design #2, which is detailed in Table 8.1. The design 
was generated with specifications as follows. For Calcium, the minimum, central and 
maximum values for factors C and F were, respectively: 5, 8, 12, and 5, 7, 10; while for 
Magnesium they were 5, 6, 8 and 5, 7, 10. The design generated specified non integer number, 
so their value was rounded to the closest integer that fit in the design. 
p. 85 
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Table 8.1: Design 2 - Central composite design 
F\CTORS 
RUN CALCIUM MAGNESIUM 
# 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
C 
(NbPts) 
5 
5 
12 
12 
3 
13 
8 
8 
8 
8 
F 
(NbKep) 
5 
10 
5 
10 
7 
7 
3 
10 
7 
7 
C 
(NbPts) 
5 
5 
8 
8 
4 
9 
6 
6 
6 
6 
F 
(NbRi 
5 
10 
5 
10 
7 
7 
3 
10 
7 
7 
8.1.2. Prediction results 
The same approach as presented in Section 6.1.1 was used to obtain responses for each run of 
design 2. 
Summarized results for the prediction of Calcium and Magnesium content for each DoE runs 
are presented in Table 8.2 as the absolute value of the relative difference between the 
prediction and the theoretical value (refer to Eq. 3). For information purposes, the same error 
was calculated for results obtained with the certified ICP method for the same commercial 
batch. They are tabulated in the last line ("ICP" in column 1). All following analysis are based 
on these results. 
Table 8.2: Prediction results for design 2 - absolute relative error 
RUN 
# 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
ICP 
CALCIUM 
% 
1.57 
1.22 
3.16 
2.87 
8.98 
0.58 
4.33 
3.75 
4.09 
4.09 
0.19 
M A C M MI M 
% 
13.41 
13.22 
31.94 
27.23 
46.28 
48.66 
15.05 
4.22 
4.34 
4.34 
1.02 
p. 87 
EFFECT SS DF MS F-VALUE P-VALUE 
(Linear) NbPts-C 
(Quadratic) NbPts-C 
(Linear) NbRep-F 
(Quadratic) NbRep-F 
(linear) C by F 
11.86667 
0.58436 
0.43401 
0.53485 
0.65622 
I 11.86667 
I 0.58436 
0.43401 
1 0.53485 
1 0.65622 
1.351094 
0.066533 
0.049414 
0.060896 
0.074715 
0.309711 
0.809181 
0.834974 
0.817233 
0.798125 
Error 35.13205 4 8.78301 
Total SS 49.42724 9 
Table 8.4: ANOVA results for Magnesium data - design 2 
FACTOR SS DF MS F*VALWE P-VALUE 
(Linear) NbPts-C 
(Quadratic) NbPts-C 
(Linear) NbRep-F 
(Quadratic) NbRep-F 
(linear) C by F 
121.852 
1873.802 
81.987 
37.313 
0.116 
1 121.852 
I 1873.802 
t 81.987 
I 37.313 
1 0.116 
3.63923 
55.96280 
2.44860 
1.11438 
0.00347 
0.129091 
0.001707 
0.192680 
0.350672 
0.955860 
Error 133.932 4 33.483 
Total SS 2552.697 9 
Results of ANOVA are also summarized in the same kind of modified Pareto chart that was 
presented earlier, illustrated in Figure 8.1. Numbers provided at the end of each bar are the t-
values (df =4). 
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Figure 8.1: Modified Pareto chart of design 2 ANOVA 
8.1.4. Interpretation of results 
In regards to results presented in Chapter 6 and Chapter 7, conclusions regarding the number 
of replicates (F) remain unchanged. Based on the p-values, the number of points (C) for 
Magnesium data remains significant, while for Calcium it appears not to be anymore. 
Moreover, additional information is now available regarding those factors. The results indicate 
that there is a strong quadratic dimension in the effect factor C has on the response when 
tested with the Magnesium data. 
This quadratic dimension deserves a deeper analysis, which can be done by looking at the 
response surface graph for the Magnesium data set, presented in Figure 8.3. Response surface 
graph for the Calcium data is also provided in Figure 8.2. 
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Figure 8.3: Response surface chart - design 2 - Magnesium 
Chapter 8. Additional design 
The response to factor C has an upside-down bell shape, particularly for Magnesium, 
indicating that mid-range number of calibration points lower the error. This shape is surprising 
and needs more analysis. 
In order to better analyze this effect, another series of models was done in order to better 
distinguish between the different possible origins of response variations that is associated to 
factor C. 
8.2. ANOVA 3 and 4 - Factor C 
8.2.1. Context and design methodology 
As mentioned previously, there is a need to better observe the effect of factor C and to 
examine all possible causes for the response variation. 
When the number of calibration points used is the maximum available, no choice is implied in 
assembling the calibration matrix. However, if the required number is lower than the 
maximum, a choice must be made regarding which calibration batch to include in the matrix. 
During this work, the priority has been 
given to 1) covering the whole range 
and 2) including batches in such 
manner as to have an even distribution 
of points along the span. With those 
constraints in mind, calibration 
matrices were prepared for each run 
with the mixes respectively circled in 
Figure 8.4. Numbers in blue indicate 
the level for factor C (y axis) and the 
calibration batch number (x axis). 
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But, as illustrated in Figure 8.5, with lower levels, several alternatives could satisfy the constraints. 
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Figure 8.5: Illustration of alternatives for calibration point selection 
Given this situation, and the fact that problems with certain batches had been spotted earlier 
(refer to Chapter 5), it is advisable to study the effect of this choice on the response. 
Additional models will be elaborated, with the calibration matrix prepared to include different 
batches combination, as detailed in Figure 8.6. This test will be referred to as ANOVA 3. It is 
a 1-factor & 5-level design. 
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Figure 8.6: Illustration of alternatives for calibration point selection 
In addition to this test, design 2 will be retested with the exclusion of factor F, meaning that 
the number of replicates included in each calibration batch will be the same, set to the 
maximum (optimal position). This will allow totally excluding the influence of factor F and 
assess if the "true" shape of the response surface for factor C truly is the upside-down bell. 
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The inclusion of any extrapolation in the response shape will also be prevented, because the fit 
of the data to the ANOVA model is not high and hence extrapolation includes unneeded 
uncertainties. This new test will be referred to as ANOVA 4 and will be a 1-factor & 5-levels 
ANOVA. 
8.2.2. Prediction results 
The same approach as presented in Section 6.1.1 was used to obtain responses for each level 
of ANOVA 3 and 4. 
Summarized results for the prediction of Calcium and Magnesium content for each level are 
presented in Table 8.5 as the absolute value of the relative difference between the predicted 
and the theoretical value. 
Table 8.5: Prediction results for ANOVA 3 &4 - absolute relative error 
LEVEL* 
A 
B 
C 
D 
E 
3(4) 
5(5) 
8(6) 
12(8) 
13(9) 
CALCIUM 
% 
5.95 
1.98 
2.03 
5.47 
1.98 
7.72 
1.98 
4.42 
1.83 
1.79 
MAGNEMl'M 
% 
48.14 
6.71 
16.89 
4.06 
13.22 
45.49 
13.22 
4.22 
27.23 
46.99 
* Numbers in parenthesis are for Magnesium 
data 
All following results and analysis are based on the full data that lead to those summarized 
results. 
8.2.3. Results and interpretation of ANOVA 3 and 4 
The analysis of the two data sets indicates that Table 8.6: Brief results for ANOVA 3 &4 
ANOVA 
# 
3 
4 
P-VALUE 
CALCIUM MAGNESIUM 
0.000001 0.00 
0.00 0.00 
both factors have a significant effect on the error 
associated with the predictive models. P-values 
are detailed in Table 8.6. 
£,.?3 
The effect of each factor can be 
better visualized using a plot of 
means. They are available in Figure 
8.7 to Figure 8.10. A word should be 
said at this point regarding the 
significance of factor C for Calcium 
data. It was previously found that it 
was not significant, whilst this new 
data points to the opposite. Those 
two conclusions are apparently in 
conflict, but when a closer look is 
taken at Figure 8.9, it can be seen 
that the difference in prediction error 
is marginal, expect for the 3-pt level 
(level 3). The levels originally tested 
were 6 and 13, and for those it can 
be seen that there is still no 
difference, thus lifting the apparent 
conflict. It is expected that when 
lowering the number of calibration 
points, at some point not enough 
data will be present in the calibration 
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data 
set to perform an adequate calibration; this is well outlined by the fact that the only major 
difference in prediction accuracy is encountered when using 3 calibration points (level 3). 
Also, it is possible to observe from Figure 8.7that, for Calcium data, level A and D represent 
those that are significantly different from the other three. The main difference between those 
selection and the others, are the presence of mixes 4 and 13. Mix 4 is used in both selections 
and in no other, while mix 13 is used also in level C. For Magnesium data, the same mix 4 and 
13 seems problematic (present in level A, C and E and no other) as well as potentially mix 7 
(which is present in level A and C and no other). 
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In the light of this new data, it is 
becoming obvious that the influence of 
factor C (number of calibration points) 
can be equally due to the selection of 
the points amongst all that are 
available as well as the added number 
of batches themselves. This could 
mean that disposing of a high number 
of calibration points from which to 
choose an adequate selection for Figure 8.97piot of means - ANOVA4 Calciuni 
model calibration might reveal to be 
more of an advantage than reducing 
the total number of available different 
batches, since it is impossible to 
foresee which batch will turn out to 
contain "good" variance and will thus 
improve the model calibration. 
As illustrated in Figure 8.9 and Figure 
8.10, the shape of the response surface 
has not changed from that determined 
from Design 2 data. The "bump" in the F i 8 u r e 8 - 1 0 : p l o t o f m e a n s ~ ANOVA 4 
Magnesium data 
Calcium data (Figure 8.7) may well be 
attributed to the addition of mix 4 in the data set (not present for levels 3 and 5) and a lower 
number of batches (when compared to levels 12 and 13). 
Overall, these additional analyses lead to the conclusion that it is probably not the actual 
number of points (factor C) that matter but rather the selection of those points together in a 
calibration matrix. The optimal level of factor C must hence be high, so the best selection can 
be made amongst available batches. This agrees with the conclusions stating that factor B 
(distribution of calibration points) has a significant effect on the response. 
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"I am careful not to confuse excellence with perfection, 'Excellence! I can 
reach for;perfection is Qod's Business" 
Michel ]. Fox (b. 1961), quoted fay Lome A. Adrain in 
The most important thing I know, 1997 
CHAPTER 9 OPTIMIZED MVPM-BASED-PAT 
DEVELOPMENT PROTOCOL 
9.1. Overview of factor significance 
As a reminder, the significance of each factor on each tested minerals is repeated here, in 
Table 9.1. 
Table 9.1: Summary of factor significance 
A-
B -
C-
D -
E -
F -
G-
FACTOR 
- Press used 
- Distribution of 
calibration points 
- Number of calibration 
points 
- Calibration algorithm 
- Use of commercial 
samples 
Number of replicates 
- Reference 
measurement method 
Batch size 
SIGNIFICANCE 
CALCIUM MAGNESIUM 
X 
V 
X 
X 
X 
X 
X 
>/ 
V 
S 
X 
X 
X 
X 
X 
9.2. Suggested optimal value for individual factors 
In Chapter 7 and in Chapter 8 were detailed the means plot for each factor. Those plots were 
used to determine the level of each tested factor that minimized the prediction error, leading to 
an optimized development protocol for MVPM-based PAT. The recommended levels for each 
of the tested factors are detailed in Table 9.2. 
The automatic press, along with a conveniently sized batch, should be used to produce a high 
number of evenly distributed calibration points. A PLS algorithm should be to calibrate the 
predictive model, using theoretical y-variables. The number of replicates can be lowered 
significantly if it allows gaining time or reducing efforts and/or costs. 
p. 95 
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Table 9.2: Recommended levels for each tested factor 
FACTOR 
(A) Type of press used 
(B) Distribution of calibration points 
(C) Number of calibration points 
(D) Calibration algorithm used 
(E) Use of commercial samples 
(F) Number of replicates 
(G) Type of reference used 
Batch volume 
TKSTEI) 
Automatic, Manual 
Concentrated, Even 
Ca: 3, 5, 6, 8,12,13 
Mg: 4, 5, 6, 8, 9 
PCR, PLS 
Absent, Present 
3,5,7,10 
Theoretical, Reference 
1,6,16,3200g 
LEVEL 
OPTIMAL 
Automatic 
Even 
High number 
-
-
-
-
-
RECOMMENDED 
Automatic 
Even 
High number 
PLS 
Absent 
5 
Theoretical 
Most convenient 
Using those sets of parameter settings allows the development of a well performing predictive 
model, at reduced cost and accelerated schedule. This optimized method was tested in order to 
verify the overall impact on performance by selecting the data in the calibration matrix that 
would have been obtained if such protocol had been used. Three (3) more models were hence 
developed, one for each of the monitorable minerals presented in Chapter 5. Prediction errors, 
calculated as the relative difference between the claim and the measure, are presented in Table 
9.3. The difference, or loss of precision, does not exceed 2.5 % in the worst case, and for a 
model that was already the weakest performing one. For the two others, the difference is much 
less significant, which tends to confirm the results obtained in the study. 
Table 9.3: Comparison of error for optimized models 
SAMPLES 
( \ i f i r .M 
I I I I MIMMM. 
M \<;M-MI M 
I I I I MIMMM. 
MlMKVI 4 
U l l . MIMMM. 
Commercial 
Difference 
full vs minimal 
9 1.9 
+1.0 
2.6 3.1 5.6 
-0.5 -2.4 
£.97 
The "expected state" for PAT development is based on the optimization work presented 
throughout this document and more specifically the main results presented in Section 9.2. Like 
the previous base case, it is presented as a summary: 
• 245 hours for the PAT leader; 
• 80 hours for various qualified personnel; 
• 180 hours of laboratory use. 
These savings are achieved with minimal impact on the final quality of the MVPM-based 
method. 
Even though the details of the calculation can not be shown here because of confidentiality 
issues, it can be reported that a minimum of 3 month-period is expected to be gained, with 
direct invested man- and lab-time reduced by approximately 30 % and development-cost, by 
31 %. 
"tin Bon mot neprouve rien." 
Voltaire (1694-1778), Le diner du cample 
de Boulainvilliers: Deuxieme entretien, 1767 
CHAPTER 10 CONCLUSION 
10.1. Summary 
The work presented in this thesis has resulted in the recommendation of an optimized 
development protocol for Process Analytical Technology based on Multivariate Predictive 
Models (MVPM-based PAT). 
It is shown that the development process of a MVPM-based PAT can be investigated and 
optimized. The selected case was the use of Raman spectroscopy to predict the content in 
target minerals in intact pharmaceutical tablets. 
A total of 8 parameters were examined, using an appropriate design of experiment. The effects 
of varying those parameters on the final MPVM were studied using the prediction error based 
on the difference between the target concentration of a commercial product and the prediction 
value. 
Several parameters were found to have no significant influence on the prediction error. This 
indicated that the levels of those factors could be optimized without affecting the final 
method's quality. The proposed optimization lies mainly in the reduction of the number of 
replicates to be measured and the recommendation to no longer use the reference 
measurements. 
While the monetary savings are not to be neglected at 31 % of development investment for a 
first application, the main advantage of these two changes is that it allows cutting the 
estimated development time by about two. This is a tremendous advantage, given the always 
limited resources that can be allocated to such projects. This time reduction allows the facility 
to undertake more different projects at the same time and hence multiply the potential gains 
and return on each system investment. 
At last, the work presented herein also contributes to fundamental sciences, in regards to both 
Raman spectroscopy used for content analysis and for multivariate data analysis used for 
predictive model calibration. 
p. 98 
p. 99 
More specifically, it was found that the number of and, most importantly, the possibility to 
select the adequate set of calibration points amongst the total number, has a very significant 
influence on the performance of the model. Being able to select the points as needed and to 
optimize the selection in regards to results obtained was found to be the most important factor 
in calibrating a model. Having this liberty should insure the analyst that he will be able to 
calibrate adequately the model. Using more replicates of the same points does not contribute 
to the final performance and hence savings can be done by acquiring less PAT measurements. 
This is an original contribution because the most frequently encountered recommendation 
regarding calibration samples is "the more the better". But producing more points is more 
costly and more time-consuming, so if no tangible gain is obtained, it is not so much better. 
The conclusions obtained from this work are hence a good basis to take a reasonable decision 
regarding the total number of samples to be manufactured en vue of the calibration. 
Moreover, the use of reference measurements, which has been considered for the most part an 
obligation, was found not to contribute significantly to model performance. The acquisition of 
such data has proven to be time and again long and costly, which is why this study's results 
are so promising and innovating. Because this had never been tested to the author's 
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knowledge, it is one of the major original contributions of this work and should reveal to be a 
major asset in future MVPM-based PAT method development. 
Also, it has been proven that the manufacturing method for development samples does not 
have much of an impact on the model's performance, as long as it allows obtaining samples 
that are homogenous. The most convenient method available to the analyst can hence be used 
without fear of compromising future performance of the method. 
Finally, the present work is based on a double analysis. Two raw materials were investigated, 
one being present in high concentration in the samples, and the other in low concentration. 
This allows obtaining conclusions that should be much more versatile. It removes the 
incertitude regarding the behaviour of the tested parameters in regard to sample composition. 
This approach has not been found in published literature, to the author's knowledge at the 
time of publication. It is hence yet another original contribution to science. 
"
fZ& reivardfor workjveli done is tfte opportunity to do more:' 
Jonas Salk (1418-1995), quoted in 50 American Heroes 
Every Kid Should Meet!, 2001 
CHAPTER 11 POSSIBLE FUTURE WORK 
A lot of work can be done to continue the work started with this project. This work can be 
separated in three great categories: 
A) work that completes this project; 
B) work that consolidate the conclusions obtained; 
C) work that widens the scope of this project. 
11.1. Filling the gaps of the study 
One of the factors tested was based on only partial information. If the reader recalls, the 
collection of reference measurements (Factor G) was not done for each individual sample 
groups, but rather to a portion of those groups. Only 3 to 4 spectra are linked to an accurate 
reference measurement, while the other 6 to 7 are linked to the average of the batch's 
measurements. This was inevitable due to the time required for testing as well as to the 
amount of powder required for the wet-chemistry based ICP method. 
Because the reference data was not complete, there is a possibility that its full advantage was 
not observed in the calibrated model. Would the models have exhibited a better accuracy if 
they had been based on a fully referenced data set? Would the potential accuracy increase 
have an effect large enough to cause factor G to become significantly influent in regards to the 
accuracy of the models? This remains to be tested in order to be able to recommend with full 
confidence that the optimized development protocol leads to results equivalent to that of the 
traditional approach, even if no reference measurements are taken. 
No other gaps are present in the data on which this work relies. 
11.2. Consolidating the conclusions 
Before adding to the line of work, the first step would be to increase the size of the validation 
matrix in order to include more than one commercial batch of samples in the predictions. In 
the present case, only 10 sample-spectra from 1 commercial batch were used to obtain the 
response on which the effects of the factors were tested. Increasing this pool would allow 
p. 10 
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increasing the confidence in the reliability of the conclusions because they would be based on 
a larger use of the model. 
When this is done, three main line of work can be pursued in order to consolidate the 
conclusions obtained. 
First, the study can be redone with different product formulations and different choices of raw 
material, while retaining the Raman spectroscopy tools. This will allow confirming that 
conclusions obtained in this work are also applicable in other similar situations. 
Also, the same kind of design can also be applied to a similar type of application that is based 
on another kind of spectroscopic tool. The same approach is encountered when calibrating 
Near Infrared (NIR) spectroscopy-based PAT, meaning that the same optimization could be 
done. There is a possibility that conclusions will differ when working with a different 
technology, but obtaining these conclusions will serve the same purpose as the present work, 
hence consolidating it. 
Finally, the conclusions of this work can be consolidated by testing the effect of the factors on 
a different type of response. For example, testing with repeatability instead of accuracy would 
allow determining whether model robustness is affected by the optimization. There is also 
another approach to testing model robustness that should reveal to be very interesting: using in 
the validation matrix samples that were obtained with 1) slightly altered Raman collection 
parameters 2) different commercial batches of the same product or even 3) different but 
similar commercial products. 
Adding these conclusions to the one from this work would allow developing a very solidly 
based and thoroughly tested optimized development protocol for MVPM-based PAT. 
11.3. Widening the scope of the project 
There is also a wide range of possible future work that would widen the present scope of this 
project. 
Concerning the calibration algorithm factor (Factor D), other calibration method could be 
tested, notably synthetic calibration, doped-sample based calibration, etc. This would allow 
exploring even more possibilities and assessing whether they are good options or not. 
_ _ p. 103 
Other factors that were not part of the present work could also be investigated regarding their 
possible effect on the final method's accuracy. When dealing with a product that is 
manufactured using a more complex protocol, for example based on wet granulation rather 
than dry mixing, several other factors could prove to influence model accuracy. Several new 
optimization possibilities could hence be tested, thus widening the scope of the present work. 
Annexes 
p. 104 
"Ms jar as the laws of mathematics refer to reafity, they are not certain; and 
as far as they are certain, they do not refer to reality." 
Albert Einstein (1879-1955), Geometry and Experience, Jan. 27 1921 
ANNEX 1 CALCULATIONS AND GENERAL 
EQUATIONS USED 
In the present Annex are detailed all equations and calculations used and/or mentioned in the 
document. Equations and calculations are displayed in alphabetical order. 
Baseline correction (linear) 
"This [correction] transforms a sloped baseline into a horizontal baseline. The technique is to 
point out two variables which should define the new baseline. These are both defined as 0, and 
the rest of the variables are transformed according to this with linear interpolation/extrapolation" 
[The Unscrambler® help files, 2009]. 
Bias 
The bias is the "systematic difference between predicted and measured values. The bias is 
computed as the average value of the residuals" [The Unscrambler® help files, 2009]. 
Where: 
y = predicted value of y Eq. 1 
i = sample number 
I = total nb of samples 
Conversion to wavenumbers 
The conversion of the spectral data to wavenumbers simply adds the exact laser frequency to 
each measured frequency (X-axis). This operation allows obtaining spectral data in absolute 
values rather than in relative values. Both expressions are in cm"1. 
Correlation 
The correlation is "a unitless measure of the amount of linear relationship between two 
variables. The correlation is computed as the co-variance between the two variables divided by 
the square root of the product of their variances. It varies from -1 to +1." [The Unscrambler® 
help files, 2009]. 
E{XY)-E{X)E{Y) Where: 
PXJ
 " MX2)-E2{X)MY2)-E2{Y) f = Vre6i?ed Vaulue ° f y Eq- 2 
v v /
 v / v v / \ /
 1 = sample number 
I = total nb of samples 
Data centering (mean centering) 
Mean centering is an operation systematically done in the modeling step, prior to running the 
regression algorithms. It consists of "subtracting the mean (average value) from a variable, for 
each data poinf [The Unscrambler® help files, 2009]. 
5ias=-2CP/-0 
1
 i=i 
p. 105 
Annex 1. Calculations and general agitations used 
Difference 
The response that is used throughout this work is the average of the absolute values of the 
relative difference between the prediction and the theoretical values. The equation used to 
obtain this data from the duplicates is presented here. 
Where: 
ZJ V U'i y>) I y> y = predicted value of y 
y = reference value 
i = sample number 
N = total nb of samples 
Difference = —  E ( l - 3 
Peak normalization 
"Normalization is used to get all data in approximately the same scaling, or to get a more even 
distribution of the variances and the average values. It is a row-oriented transformation, that is to 
say the contents of a cell are likely to be influenced by its horizontal neighbors. [...] Peak 
normalization normalizes a sample as the ratio of each value by the value at a selected spectral 
point (or wavelength). The chosen spectral point (usually the maximum peak of a band of the 
constant constituent, or the isosbestic point) is assumed to be concentration invariant in all 
samples" [The Unscrambler® help files, 2009]. 
Y Where: 
- A • L 
Y — - k = x-variable number Eq. 4 i,k
 ~ x 
i,k=peak 
Relative Standard Deviation (RSD) 
"The standard deviation is a measure of the dispersion of the values in respect to the mean 
value" [Microsoft Excel® help files, 2009]. In the present work, the RSD is calculated as the SD 
divided by the mean, reported in percentage. 
lY(x-x)2 Where: 
SD = , ^=9 ^ - n = nb of samples E<1- 5 
RSD = — xlOO Eq.6 
Return on investment (ROD 
The return on investment is calculated on the basis most appropriate in each situation. In can be 
monthly, yearly, or any other basis. 
R Q I = Revenu-Expenses E q 7 
Investment 
Root Mean Square Error of Cross Validation (RMSECV) 
The RMSECV is "a measurement of the average difference between predicted and measured 
response values, at the [...] validation stage" of the model calculations. "[It] can be interpreted as 
p. 107 
N„ 
IMSECV = 
±
 tot s=\ 
1 
-t* 
-1 J weights *—l 
Where: 
F = y-residuals; 
•('./) j = y-variable number; Eq.8 
Weight = -
^(x^-Centf 1
 T - 1 
•*• C iecalibrationsamptes 
Cent = — Y,xuk 
*• c iecalibrationsamples 
C = 1 if model is centered and 0 if not 
Eq.9 
Eq. 10 
Root Mean Square Error of Prediction 
N 
RMSEP i=i 
N 
Where: 
y = predicted y-value 
N = number of samples Eq. 11 
R-square (R2) 
"The R-square of a regression model is a measure of the quality of the model, computed as the 
square of the correlation coefficient between predicted and measured values. Its value is always 
between 0 an 1. The closer to 1, the better [it is]" [The Unscrambler® help files, 2009]. 
R2 = 
Where: 
x,y = mean values Eq. 12 
'""Eacfi decision we make./ each, action we. take., is Born out of an intention." 
Sharon Salzberg (b. 1952), O Magazine, The Power 
of Intention, January 2004 
ANNEX 2 DETERMINATION OF 
ACQUISITION PARAMETERS FOR 
SPECTRA COLLECTION 
The collection of Raman spectra requires that values be chosen for several acquisition 
parameters. Those parameters are listed in Table A2-01, along with their possible values and 
expected effect on spectra. 
Table A2-01: Possible acquisition parameters for Raman spectra collection 
PARAMETER POSSIBLE VALUES EXPECTED EFFECT ON SPECTRA 
Laser wavelength 
Laser power 
Spectrometer aperture 
Wavenumber span 
Exposure time 
Number of exposures 
Background exposures 
Beam dimensions 
Cosmic ray threshold 
532 or 780 nm 
0tol50mW 
25 and 50 urn slit or 
pinhole 
Range within 47 to 
3388 cm"1 
>0sec 
>1 
use of smart 
backgrounds or 
collection before 
spectra 
as is or with beam 
expander up to 5mm 
x5mm 
none, low, medium 
or high 
With higher wavelength, diminution of overall 
Raman intensity for a given exposure time and 
lower fluorescence occurrence. 
For a given exposure time, higher power leads to 
overall higher Raman intensity. 
The bigger the aperture, the more light is allowed in 
the spectrometer and hence the less noisy the 
spectrum is. 
Peaks visible on wavenumbers not included in the 
collection will not be part of the spectra. 
For a given laser power, increased time leads to 
overall higher Raman intensity. 
Increased number of exposures leads to decreased 
level of noise, but may also lead to photobleaching 
phenomenon. All exposures are averaged into a 
single spectrum before final data display. 
Collecting before each measurement allows to 
remove the background noise due to the 
instrument's actual state but increases the overall 
time for a given measurement. 
Increased beam dimensions allow collecting a 
bigger portion of the overall sample and thus 
decreases potential problems linked to sub 
sampling. 
Higher threshold increases tolerance of the system 
for random shot noise and may lead to noisy 
spectra. 
p. 108 
_ _ _ _ ___ p. 109 
In order to select the adequate setting for each parameter, a test was made with a standard 
polystyrene sample. Of the possible factors, 5 were chosen to be part of the study: 
• type of background exposure; 
. laser power; 
• exposure time; 
• number of exposures; 
• aperture. 
A 25"1 fractional factorial design of experiment was used. This design features a resolution of V, 
which allows reducing the total number of required runs while still allowing the analysis of factor 
interaction effects. The design, including the settings for each factor, is detailed in Table A2-02. 
Table A2-02: Details of the design of experiment used in the acquisition parameters test 
FACTORS 
RUN 
# 
1 
"i 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
BACKGROUND 
COLLECTION* 
smart 
before 
smart 
before 
smart 
before 
smart 
before 
smart 
before 
smart 
before 
smart 
before 
smart 
before 
30 
30 
80 
80 
30 
30 
80 
80 
30 
30 
80 
80 
30 
30 
80 
80 
EXPOSURE 
TIME 
4 
4 
4 
4 
8 
8 
8 
8 
4 
4 
4 
4 
8 
8 
8 
8 
NBOF 
EXPOSURES 
-\ 
• " > 
2 
2 
2 
2 
2 
2 
10 
10 
10 
10 
10 
10 
10 
10 
APERTIRE 
5«>f.im slit 
25 I'III niiiholc 
2 5 Jim pinhole 
50 urn slit 
25(im pinhole 
50um slit 
50nm slit 
25um pinhole 
2 5 |xm pinhole 
50|am slit 
50nm slit 
25jim pinhole 
50um slit 
2 5 |am pinhole 
25nm pinhole 
50nm slit 
* "smart' denotes the use of the smart background option, which uses background 
collected at the user-requested frequency (every 30 days) 
"before" denotes that background exposures were collected right before the 
sample exposure 
Each run represents a spectrum that was acquired with the software options set according to the 
design of that particular run. Sixteen spectra were hence acquired for later examination and are 
presented in Figure A2-01. 
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Figure A2-01: Raw spectra of Polystyrene standard 
The analysis of the design requires that Y variables be selected to test the effect of the factors. 
Several possibilities were available and the following were chosen: 
. peak height; 
. peak height ratio; 
. baseline height; 
• peak to baseline height ratio; 
. overall noise level. 
Values for each Y variable were acquired as follows: 
a) peak heights of 3 peaks were obtained from the spectra. Peaks were chosen to represent 
low, medium and high order of magnitude and are respectively located at 619.0987, 
3052.823 and 998.0424 cm"1; 
b) baseline height was obtained as an average of the baseline value over a short 
wavenumber span, from 2097.268 to 2105.946 cm"1; 
c) ratios were obtained by dividing the value of one peak by the other; 
d) overall noise level was taken as the Root Mean Square (RMS) noise calculated by the 
acquisition software over the whole spectral range. The software calculates the RMS 
noise in the following manner: 1) the best linear fit to the baseline is removed from the 
p. I l l 
signal, then 2) the RMS noise level is equal to the square root of the average of the square 
of linearly corrected values, as detailed by Eq. 13. 
RMS = i 
Zte-502 fc&i-xfoi-yit 
—\2 Ifc-sJ Eq. 13 
n — 2 
where: 
. y; refers to the intensity at a data point 
. xi refers to the X value of the data point 
• a bar over a variable indicates arithmetic mean 
. n is the total number of data points 
Results of the test are detailed in Table A2-03. Linking those results with the factor level detailed 
in Table A2-02 allows drawing conclusions about the effect each separate factors and each 
combination of factor interaction have on each individual variable. 
Table A2-03: Details of the results obtained in the test 
RlN 
I 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
BASEUJNK 
V) ^3 
3.85 
2.92 
103.44 
0.40 
38.24 
147.17 
5.16 
3.81 
56.71 
141.11 
6.12 
57.89 
2.55 
4.29 
161.17 
PKAK A 
335.77 
13.99 
40.46 
937.27 
13.73 
333.42 
988.57 
41.57 
16.35 
361.02 
963.69 
38.89 
362.56 
14.98 
39.46 
993.61 
PKAK B 
688.86 
15.22 
64.46 
1938.79 
23.6 
673.88 
1915.02 
62.96 
30.26 
681.34 
1866.28 
59.08 
666.59 
23.51 
62.36 
1907.58 
PEAK C 
1885.18 
79.37 
232.29 
5261.66 
78.35 
1830.91 
4907.28 
221.59 
81.35 
1860.49 
4969.49 
219.18 
1813.6 
77.05 
224.06 
4975.55 
RATIO 
A/B 
0.48 
0.91 
0.62 
0.48 
0.58 
0.49 
0.51 
0.66 
0.54 
0.52 
0.51 
0.65 
0.54 
0.63 
0.63 
0.52 
RATIO 
A/C 
0.17 
0.17 
0.17 
0.17 
0.17 
0.18 
0.2 
0.18 
0.2 
0.19 
0.19 
0.17 
0.19 
0.19 
0.17 
0.19 
RATIO 
B/C 
0.36 
0.19 
0.27 
0.36 
0.3 
0.36 
0.39 
0.28 
0.37 
0.36 
0.37 
0.26 
0.36 
0.3 
0.27 
0.38 
RATIO 
A/BASKMNK 
8.53 
3.62 
13.84 
9.06 
33.86 
8.71 
6.71 
8.04 
4.28 
6.36 
6.82 
6.34 
6.26 
5.86 
9.18 
6.16 
RMS 
124.8 
6.5 
14.3 
355.2 
5.1 
122.5 
337.7 
13.4 
5.1 
123.4 
335.0 
12.8 
120.6 
4.7 
13.3 
337.9 
The first results indicate that the type of background collection used do not significantly affect 
any of the Y variable tested, which allows using this factor as a blocking variable. This creates a 
data set containing 2 replicates of a 24 full fractional design. An ANOVA analysis can be 
conducted on the remaining factors and interaction. Results are detailed in Table A2-04, where 
the statistically significant factors are numbered by decreasing importance for each Y variable. A 
cell with no number indicates that the particular factor or interaction is not statistically significant 
in regard to the Y variable in the given column. P-values for each factor and interaction are 
detailed in Table A2-05. A factor, or an interaction of factors, is considered to significantly affect 
the dependent variable when its calculated p-value is lower than 0.05, for a 5 % confidence 
interval. 
Annex 2, Determination of acquisition parameters for spectra collection 
Overall, the results indicate that the 2 most important factors are the aperture and laser power 
used, as well as their interaction. They affect net peak height and overall noise level. Other 
factors have p-values that are close to the 5 % limit, indicating that, while not being statistically 
significant at a level of 5 %, they remain somewhat of importance and could reveal to be of 
influence in other situations. 
Another important result is that most factors do not appear to influence peak height ratio. This is 
a good indicator that spectral pre-treatments that include peak normalization could be good 
avenues to insure multivariate predictive model robustness. Also, the ratio "peak to baseline" is 
not significantly affected by any of the factors tested. 
Table A2-04: Factors and interactions significantly affecting tested spectral variables 
FACTOR N ^ 
Laser power 
Nb exposure 
Aperture 
1x3 
1x4 
BA.SF.UNE 
• » 
1 
3 
PEAK 
A 
1 
1 
3 
PEAK 
B 
"» 
1 
3 
PEAK 
C 
t 
1 
3 
Rvno 
A/B 
1 
RATIO 
A/C 
1 
2 
RATIO 
B/C 
l 
RATIO 
PEAK TO 
BASELINE 
RMS 
1 
3 
Table A2-05: p-
"^VVARIABI.I : 
F A C T O R ^ 
Background 
Laser power 
Exposure 
time 
Nb exposure 
Aperture 
1x2 
1x3 
1x4 
2x3 
2x4 
3x4 
BASELINE 
0.M194 
( I.I >i in? 
0.1691 
0.0588 
o.OOOO 
0.1250 
0.6975 
' ».0006 
0.5484 
0.1276 
0.0768 
values of factors and interactions for all tested Y variables 
PEAK 
A 
O.S^SO 
0.00'H 
0.1328 
0.1151 
0.0000 
0.1165 
0.5184 
0.0000 
0.6774 
0.1332 
0.1147 
PEAK 
B 
0.5295 
D.OlHiO 
0.8995 
0.2595 
0.0000 
0.5083 
0.2582 
0.0000 
0.4477 
0.8229 
0.1876 
PEAK 
c 
0.3245 
(1.0000 
0.1968 
0.4067 
0.0000 
0.4523 
0.5518 
0.0000 
0.2708 
0.2150 
0.4385 
RATIO 
A/B 
n.3086 
0."899 
0.7175 
0.6485 
0.0388 
0.5229 
0.5229 
0.8271 
0.4160 
0.4944 
0.3086 
RATIO 
A/C 
0.4601 
0.4601 
0.1778 
0.0309 
0.0705 
0.1778 
0.0309 
0.0705 
0.0705 
0.1778 
1.0000 
RATIO 
B/C 
0.2637 
0.9029 
0.5514 
0.3574 
0.0104 
0.9029 
0.2637 
0.4146 
0.2637 
0.9029 
0.3574 
RATIO 
PEAK TO 
BASELINE 
0.2948 
0.7037 
0.4449 
0.2277 
0.4938 
0.2633 
0.4698 
0.7634 
0.5609 
0.3331 
0.4551 
RMS 
0.291" 
i).! 11)00 
0.2655 
0.1929 
0.0000 
0.6588 
0.3859 
0.0000 
0.2611 
0.3627 
0.3053 
*Note: factors that are considered significant for each individual dependent variable, based on their p-values, 
are emphasized in light grey. 
"Sometimespeople are layered iik$ tfiai, 'There'ssomething totally different 
underneath than what's on the surface. ''But sometimes, there's a third, even 
deeper level, and that one is the same as the top surface one, Like- with pie" 
Joss Whedon, Zack Whedon, Mantissa Tancharoen and Jed Whedon, 
Dr. Horrible's Sing Along Blog, 2008 
ANNEX 3 DEPTH OF MEASUREMENT 
DETERMINATION 
The present annex describes the work that was done in order to estimate the depth of 
measurement of the Raman spectroscopic system with the development samples. 
Test samples were prepared in order to feature, at various depths, a layer of a material 
displaying a characteristic peak. The tablets were hence composed of two layers of "blank 
material" that surrounded a layer of "test material". 
The blank layers were composed of a mixture of dye, Calcium Carbonate and Sorbitol, in 
proportions similar to those of the development samples used for model calibrations. The test 
material was a Manganese-based raw material. 
In order to obtain layered tablets, the powder was successively deposited in the matrix. The 
upper punch was slightly tapped upon the powder surface to level it before adding the 
subsequent layer. Compression was made using same material and conditions as described in 
Chapter 3. Characteristics of prepared samples are detailed in Table A3-01. 
Raman spectra of prepared samples were obtained using the same parameters as described in 
Chapter 3. They were corrected for linear baseline (Xi = 695.87347 and X2 = 1809.56 cm"1) 
and normalized (X = 2927.11 cm"1). Corrected spectra are displayed in Figure A3-01, between 
600 and 1200 cm"1. 
Table A3-01: Tests samples characteristics 
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It can be seen from Figure A3-01 that a characteristic peak is easily observable on the sample 
that was measured with the Manganese directly on the measurement window (Depth 1 
sample). The peak is smaller but still observable at a depth of 0.5mm but is doesn't appear 
anymore at 1.5 mm depth. 
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Annex 3. Depth of measurement 
Raman shift (cm-1) 
FigureA3-01: Raman spectra of test samples 
In order to increase the resolution of the test, a second series of samples was prepared, with 
characteristics described in Table A3-02. The thickness of the bottom layer, indicating how far 
away from the laser the "active" layer is, was measured more precisely for this series of 
samples. After the collection of the Raman spectra, the tablet was broken to separate the active 
from the bottom layer and the latter was scrapped from all remaining active. The ensuing purple 
disc's thickness was measured using a Mitutoyo 0.8-0.001 inch Caliper. The conversion from 
inches to millimeters was achieved using the factor 25.4 mm/in. 
Raman spectra were treated alike that of the first series of 3-layer samples and are displayed in 
Figure A3-02. 
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Raman shift (cm-1) 
FigureA3-02: Raman spectra of series 2 test samples 
It can be observed from Figure A3-02 that the peak associated with Manganese is clearly 
present at 1.1 mm deep, but disappears in the other samples. 
The small peak that is observable at 1.5 mm but not at 1.4 mm can be explained by local 
migration of the Manganese in the powder during the compaction and compression. Moreover, 
since the center layer of the samples was not stable and tended to disaggregate after 
compaction, "contamination" of the first layer by the active was also a problem. 
Given those limitations, a working value of 1 mm will be used as the approximation of the actual 
system's sample probing-depth. 
Table A3-02 
DISTANCE 
A (mm) 
EJ (mm) 
: Tests samples characteristics - series 2 
Di-mi ft DEPTH 7 D E P T H S DEPTH 9 
3.<) 3.8 3.7 4.0 
I.I 1.4 1.5 1.7 
"Mathematicians are li^e frenchmen: whatever you say to them they translate 
into their own language, and forthuntfi it is something entirely different" 
Johann Wolfgang von Goethe (1749-1832), Unsourcetl 
ANNEX 4 ANALYSIS OF RESIDUALS - ANOVA 
RESULTS 
DESIGN 1 DATA- CALCIUM ANALYSIS 
Verification of assumptions for ANOVA 
An ANOVA relies on several assumptions that must be satisfied. The observations must be 
free of outliers, and the errors must be normally, independently and structurelessly distributed 
with mean zero and constant variance a2. "If these assumptions are valid, the analysis of 
variance procedure is an exact test of the hypothesis of no difference in treatment means. [...] 
Violations of the basic assumptions and model adequacy can be easily investigated by the 
examination of residuals [as defined by equation (A4-01)]" [Montgomery, 2001]. In the 
special case of balanced design, the equality of variances is not as crucial an assumption as 
some of the others [Statistica, 2008]. 
e.. = v..-y. (A4-01) 
The normal probability plot of raw residuals for the response variable for the study of the 
Calcium data is shown in Figure A4-01. Normality of distribution is hence verified. Residuals 
were checked for structure or trend and none could be found when observing the Raw 
Residuals vs Predicted Values and Raw Residuals vs Case Number graphs, satisfying the 
independence of distribution assumption. Both are illustrated in Figures A4-02 and A4-03. 
Figure A4-01: Normal probability plot of raw residuals 
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Residuals vs. Case Numbers 
6 factors at two levels: MS Residuat=1.36274 
Predicted vs. Residual Values 
6factors at two levels; MS Residuat=1.36274 
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Figure A4-02: Raw Residuals vs Case 
Numbers graph 
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Figure A4-03: Raw residuals vs Predicted 
Values graph 
DESIGN 1 DATA- MAGNESIUM ANALYSIS 
Verification of assumptions for ANOVA 
The normal probability plot of raw residuals for the response variable for the study of the 
Calcium data is shown in Figure A4-04. Normality of distribution is hence verified. Residuals 
were checked for structure or trend and none could be found when observing the Raw 
Residuals vs Predicted Values and Raw Residuals vs Case Number graphs, satisfying the 
independence of distribution assumption. Both are illustrated in Figures A4-05 and A4-06. 
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Figure A4-04: Normal probability plot of raw residuals 
Annex 4. Analysis of residuals - ANOVA results 
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Figure A4-06: Raw residuals vs Predicted 
Values graph - transformed response 
variable 
DESIGN 1 DATA- COLLAPSED CALCIUM ANALYSIS 
Verification of assumptions for ANOVA 
The normal probability plot of raw residuals for the response variable for the study of the 
Calcium data is shown in Figure A4-07. Normality of distribution is hence verified. Residuals 
were checked for structure or trend and none could be found when observing the Raw 
Residuals vs Predicted Values and Raw Residuals vs Case Number graphs, satisfying the 
independence of distribution assumption. Both are illustrated in Figures A4-08 and A4-09. 
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Figure A4-07: Normal probability plot of raw residuals 
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Figure A4-09: Raw residuals vs Predicted 
Values graph - transformed response 
variable 
DESIGN 1 DATA- COLLAPSED MAGNESIUM ANALYSIS 
Verification of assumptions for ANOVA 
The normal probability plot of raw residuals for the response variable for the study of the 
Calcium data is shown in Figure A4-10. Normality of distribution is hence verified. Residuals 
were checked for structure or trend and none could be found when observing the Raw 
Residuals vs Predicted Values and Raw Residuals vs Case Number graphs, satisfying the 
independence of distribution assumption. Both are illustrated in Figures A4-11 and A4-12. 
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Figure A4-10: Normal probability plot of raw residuals 
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Figure A4-12: Raw residuals vs Predicted 
Values graph - transformed response 
variable 
BATCH-VOLUME EFFECT DATA- CALCIUM DATA 
Verification of assumptions for ANOVA 
The normal probability plot of raw residuals for the response variable for the study of the data 
is shown in Figure A4-13. Normality of distribution is hence verified. Residuals were checked 
for structure or trend and none could be found when observing the Raw Residuals vs Predicted 
Values, satisfying the independence of distribution assumption, as illustrated in Figures A4-14. 
No outliers could be found in any of the two plots. 
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BATCH-VOLUME EFFECT DATA- MAGNESIUM DATA 
Verification of assumptions for ANOVA 
The normal probability plot of raw residuals for the response variable for the study of the data 
is shown in Figure A4-15. Normality of distribution is hence verified. Residuals were checked 
for structure or trend and none could be found when observing the Raw Residuals vs Predicted 
Values, satisfying the independence of distribution assumption, as illustrated in Figures A4-16. 
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DESIGN 2 DATA- CALCIUM ANALYSIS 
Verification of assumptions for ANOVA 
The normal probability plot of raw residuals for the response variable for the study of the data 
is shown in Figure A4-17. Distribution is not perfectly normal, but using a BOXCOX 
transformation did not allow correcting it. Analysis was hence continued with this data, since 
the distribution was not too far from a normal one. Residuals were checked for structure or 
trend and none could be found when observing the Raw Residuals vs Predicted Values, 
satisfying the independence of distribution assumption, as illustrated in Figures A4-18. 
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DESIGN 2 DATA- MAGNESIUM ANALYSIS 
Verification of assumptions for ANOVA 
The normal probability plot of raw residuals for the response variable for the study of the data 
is shown in Figure A4-19. Normality of distribution is verified. Residuals were checked for 
structure or trend and none could be found when observing the Raw Residuals vs Predicted 
Values, satisfying the independence of distribution assumption, as illustrated in Figures A4-20. 
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ANOVA 3 DATA - CALCIUM ANALYSIS 
The normal probability plot of raw residuals for the response variable for the study of the data 
is shown in Figure A4-08. Normality of distribution is hence verified for each group of data. 
Levene test was performed to test homogeneity of variance. P-value for Calcium data was 
lower than 0.05, indicating that differences in variance are not likely to have occurred has part 
of a random sampling. However, the ANOVA test is robust to inhomogeneity of variance 
when the number of samples within each group is constant, which is the case in the present 
study. 
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Annex 4, Analysis of residuals - ANOVA results 
ANOVA 3 DATA - MAGNESIUM ANALYSIS 
The normal probability plot of raw residuals for the response variable for the study of the data 
is shown in Figure A4-09. Normality of distribution is hence verified for each group of data. 
Levene test was performed to test homogeneity of variance. P-value for Magnesium data was 
lower than 0.05, indicating that differences in variance are not likely to have occurred has part 
of a random sampling. However, the ANOVA test is robust to inhomogeneity of variance 
when the number of samples within each group is constant, which is the case in the present 
study. 
2.0 
1.5 
1.0 
0.5 
0.0 
-0.5 
-1.0 
-1.5 
2.0 
1.5 
1.0 
0.5 
0.0 
-0.5 
-1.0 
-1.5 
-2.0 
Probability Plot: 3/DiffMg 
/ ! p/ 
-2.0 * 
-10 
[A 
0 10 20 30 40 50 60 70 -10 0 10 20 30 40 50 60 70 -10 0 10 20 30 40 50 60 70 
Level:: 1 Level: 2 Lewi; 3 
-10 0 10 20 30 40 50 60 70 -10 0 10 20 30 40 50 §0 70 
Level: 4 Level: 5 
Figure A4-09: Normal probability plots for each data group 
L-*» X JC^I^/ 
ANOVA 4 DATA - CALCIUM ANALYSIS 
The normal probability plot of raw residuals for the response variable for the study of the data 
is shown in Figure A4-10. Normality of distribution is hence verified for each group of data. 
Levene test was performed to test homogeneity of variance. P-value for Calcium data was 
lower than 0.05, indicating that differences in variance are not likely to have occurred has part 
of a random sampling. However, the ANOVA test is robust to inhomogeneity of variance 
when the number of samples within each group is constant, which is the case in the present 
study. 
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Annex 4. Analysis of residuals - ANOVA results 
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ANOVA 4 DATA - MAGNESIUM ANALYSIS 
The normal probability plot of raw residuals for the response variable for the study of the data 
is shown in Figure A4-11. Normality of distribution is hence verified for each group of data. 
Levene test was performed to test homogeneity of variance. P-value for Magnesium data was 
higher than 0.05, indicating that differences in variance are likely to have occurred has part of 
a random sampling. 
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